Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for SP3
Z-value: 2.45
Motif logo
Transcription factors associated with SP3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SP3
|
ENSG00000172845.9 | Sp3 transcription factor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SP3 | hg19_v2_chr2_-_174830430_174830563 | 0.10 | 6.8e-01 | Click! |
Activity profile of SP3 motif
Sorted Z-values of SP3 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr7_+_5322561 | 17.58 |
ENST00000396872.3
ENST00000444741.1 ENST00000297195.4 ENST00000406453.3 |
SLC29A4
|
solute carrier family 29 (equilibrative nucleoside transporter), member 4 |
| chr16_+_1203194 | 14.81 |
ENST00000348261.5
ENST00000358590.4 |
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
| chr11_+_57227981 | 14.12 |
ENST00000335099.3
|
RTN4RL2
|
reticulon 4 receptor-like 2 |
| chr5_-_179780312 | 12.95 |
ENST00000253778.8
|
GFPT2
|
glutamine-fructose-6-phosphate transaminase 2 |
| chr16_+_2039946 | 12.56 |
ENST00000248121.2
ENST00000568896.1 |
SYNGR3
|
synaptogyrin 3 |
| chr19_+_589893 | 12.45 |
ENST00000251287.2
|
HCN2
|
hyperpolarization activated cyclic nucleotide-gated potassium channel 2 |
| chr9_+_139606983 | 12.31 |
ENST00000371692.4
|
FAM69B
|
family with sequence similarity 69, member B |
| chr2_+_8822113 | 11.99 |
ENST00000396290.1
ENST00000331129.3 |
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
| chr21_+_46825032 | 11.84 |
ENST00000400337.2
|
COL18A1
|
collagen, type XVIII, alpha 1 |
| chr20_-_62130474 | 11.74 |
ENST00000217182.3
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
| chr3_-_13461807 | 11.61 |
ENST00000254508.5
|
NUP210
|
nucleoporin 210kDa |
| chr3_-_129325660 | 11.50 |
ENST00000324093.4
ENST00000393239.1 |
PLXND1
|
plexin D1 |
| chr22_-_30970560 | 11.43 |
ENST00000402369.1
ENST00000406361.1 |
GAL3ST1
|
galactose-3-O-sulfotransferase 1 |
| chrX_-_153775426 | 10.81 |
ENST00000393562.2
|
G6PD
|
glucose-6-phosphate dehydrogenase |
| chr2_+_42275153 | 10.41 |
ENST00000294964.5
|
PKDCC
|
protein kinase domain containing, cytoplasmic |
| chr8_-_142318398 | 10.41 |
ENST00000520137.1
|
SLC45A4
|
solute carrier family 45, member 4 |
| chr14_+_105953246 | 10.35 |
ENST00000392531.3
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
| chr12_-_117537240 | 10.19 |
ENST00000392545.4
ENST00000541210.1 ENST00000335209.7 |
TESC
|
tescalcin |
| chr14_+_105953204 | 10.11 |
ENST00000409393.2
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
| chr15_-_27018175 | 9.87 |
ENST00000311550.5
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
| chr19_-_8675559 | 9.69 |
ENST00000597188.1
|
ADAMTS10
|
ADAM metallopeptidase with thrombospondin type 1 motif, 10 |
| chr11_-_407103 | 9.63 |
ENST00000526395.1
|
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
| chr6_+_1389989 | 9.31 |
ENST00000259806.1
|
FOXF2
|
forkhead box F2 |
| chr22_+_50946645 | 9.30 |
ENST00000420993.2
ENST00000395698.3 ENST00000395701.3 ENST00000523045.1 ENST00000299821.11 |
NCAPH2
|
non-SMC condensin II complex, subunit H2 |
| chr1_-_212873267 | 9.29 |
ENST00000243440.1
|
BATF3
|
basic leucine zipper transcription factor, ATF-like 3 |
| chr19_+_709101 | 9.08 |
ENST00000338448.5
|
PALM
|
paralemmin |
| chr16_+_89894875 | 9.03 |
ENST00000393062.2
|
SPIRE2
|
spire-type actin nucleation factor 2 |
| chr5_+_175298487 | 9.01 |
ENST00000393745.3
|
CPLX2
|
complexin 2 |
| chr17_+_64961026 | 8.98 |
ENST00000262138.3
|
CACNG4
|
calcium channel, voltage-dependent, gamma subunit 4 |
| chr2_+_234263120 | 8.95 |
ENST00000264057.2
ENST00000427930.1 |
DGKD
|
diacylglycerol kinase, delta 130kDa |
| chr5_+_175299743 | 8.90 |
ENST00000502265.1
|
CPLX2
|
complexin 2 |
| chr5_+_176513895 | 8.84 |
ENST00000503708.1
ENST00000393648.2 ENST00000514472.1 ENST00000502906.1 ENST00000292410.3 ENST00000510911.1 |
FGFR4
|
fibroblast growth factor receptor 4 |
| chr17_-_76183111 | 8.78 |
ENST00000405273.1
ENST00000590862.1 ENST00000590430.1 ENST00000586613.1 |
TK1
|
thymidine kinase 1, soluble |
| chr2_-_233792837 | 8.76 |
ENST00000373552.4
ENST00000409079.1 |
NGEF
|
neuronal guanine nucleotide exchange factor |
| chr14_+_105992906 | 8.71 |
ENST00000392519.2
|
TMEM121
|
transmembrane protein 121 |
| chr20_-_22565101 | 8.69 |
ENST00000419308.2
|
FOXA2
|
forkhead box A2 |
| chr2_+_121103706 | 8.52 |
ENST00000295228.3
|
INHBB
|
inhibin, beta B |
| chr20_+_33814457 | 8.50 |
ENST00000246186.6
|
MMP24
|
matrix metallopeptidase 24 (membrane-inserted) |
| chr19_-_55919087 | 8.48 |
ENST00000587845.1
ENST00000589978.1 ENST00000264552.9 |
UBE2S
|
ubiquitin-conjugating enzyme E2S |
| chr16_+_89894911 | 8.41 |
ENST00000378247.3
ENST00000563972.1 |
SPIRE2
|
spire-type actin nucleation factor 2 |
| chr9_+_140317802 | 8.35 |
ENST00000341349.2
ENST00000392815.2 |
NOXA1
|
NADPH oxidase activator 1 |
| chr19_+_16435625 | 8.29 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
| chr18_+_11981427 | 8.21 |
ENST00000269159.3
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr2_-_107503558 | 8.20 |
ENST00000361686.4
ENST00000409087.3 |
ST6GAL2
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 2 |
| chr14_-_102976135 | 8.16 |
ENST00000560748.1
|
ANKRD9
|
ankyrin repeat domain 9 |
| chr9_-_6645628 | 8.15 |
ENST00000321612.6
|
GLDC
|
glycine dehydrogenase (decarboxylating) |
| chr20_-_61885826 | 8.14 |
ENST00000370316.3
|
NKAIN4
|
Na+/K+ transporting ATPase interacting 4 |
| chr7_+_36192758 | 8.10 |
ENST00000242108.4
|
EEPD1
|
endonuclease/exonuclease/phosphatase family domain containing 1 |
| chr16_+_84002234 | 8.08 |
ENST00000305202.4
|
NECAB2
|
N-terminal EF-hand calcium binding protein 2 |
| chr19_+_51152702 | 8.06 |
ENST00000425202.1
|
C19orf81
|
chromosome 19 open reading frame 81 |
| chr19_-_38747172 | 8.05 |
ENST00000347262.4
ENST00000591585.1 ENST00000301242.4 |
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
| chrX_-_153775047 | 8.05 |
ENST00000433845.1
ENST00000439227.1 |
G6PD
|
glucose-6-phosphate dehydrogenase |
| chr22_-_22900001 | 8.05 |
ENST00000403441.1
|
PRAME
|
preferentially expressed antigen in melanoma |
| chr19_-_33555780 | 7.96 |
ENST00000254260.3
ENST00000400226.4 |
RHPN2
|
rhophilin, Rho GTPase binding protein 2 |
| chr19_+_35491174 | 7.87 |
ENST00000317991.5
ENST00000504615.2 |
GRAMD1A
|
GRAM domain containing 1A |
| chr8_-_145743164 | 7.85 |
ENST00000428558.2
|
RECQL4
|
RecQ protein-like 4 |
| chr19_-_48673552 | 7.84 |
ENST00000536218.1
ENST00000596549.1 |
LIG1
|
ligase I, DNA, ATP-dependent |
| chrX_-_153775760 | 7.81 |
ENST00000440967.1
ENST00000393564.2 ENST00000369620.2 |
G6PD
|
glucose-6-phosphate dehydrogenase |
| chr19_-_55658281 | 7.71 |
ENST00000585321.2
ENST00000587465.2 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr2_+_10442993 | 7.71 |
ENST00000423674.1
ENST00000307845.3 |
HPCAL1
|
hippocalcin-like 1 |
| chr19_+_14544099 | 7.71 |
ENST00000242783.6
ENST00000586557.1 ENST00000590097.1 |
PKN1
|
protein kinase N1 |
| chr19_+_708910 | 7.71 |
ENST00000264560.7
|
PALM
|
paralemmin |
| chr19_+_36545833 | 7.67 |
ENST00000401500.2
ENST00000270301.7 ENST00000427823.2 |
WDR62
|
WD repeat domain 62 |
| chr16_-_54963026 | 7.63 |
ENST00000560208.1
ENST00000557792.1 |
CRNDE
|
colorectal neoplasia differentially expressed (non-protein coding) |
| chr8_+_21906433 | 7.63 |
ENST00000522148.1
|
DMTN
|
dematin actin binding protein |
| chr8_-_72756667 | 7.60 |
ENST00000325509.4
|
MSC
|
musculin |
| chr12_+_3068544 | 7.57 |
ENST00000540314.1
ENST00000536826.1 ENST00000359864.2 |
TEAD4
|
TEA domain family member 4 |
| chr5_+_175298573 | 7.57 |
ENST00000512824.1
|
CPLX2
|
complexin 2 |
| chr15_+_78857870 | 7.57 |
ENST00000559554.1
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal) |
| chr14_+_105957402 | 7.57 |
ENST00000421892.1
ENST00000334656.7 ENST00000451719.1 ENST00000392522.3 ENST00000392523.4 ENST00000354560.6 ENST00000450383.1 |
C14orf80
|
chromosome 14 open reading frame 80 |
| chr17_+_77751931 | 7.51 |
ENST00000310942.4
ENST00000269399.5 |
CBX2
|
chromobox homolog 2 |
| chr19_+_33685490 | 7.50 |
ENST00000253193.7
|
LRP3
|
low density lipoprotein receptor-related protein 3 |
| chr10_+_30723105 | 7.47 |
ENST00000375322.2
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8 |
| chr17_-_63557759 | 7.38 |
ENST00000307078.5
|
AXIN2
|
axin 2 |
| chr15_-_56035177 | 7.37 |
ENST00000389286.4
ENST00000561292.1 |
PRTG
|
protogenin |
| chr11_-_93276582 | 7.33 |
ENST00000298966.2
|
SMCO4
|
single-pass membrane protein with coiled-coil domains 4 |
| chr9_+_139886846 | 7.30 |
ENST00000371620.3
|
C9orf142
|
chromosome 9 open reading frame 142 |
| chrX_-_153707545 | 7.28 |
ENST00000357360.4
|
LAGE3
|
L antigen family, member 3 |
| chr4_+_2043689 | 7.26 |
ENST00000382878.3
ENST00000409248.4 |
C4orf48
|
chromosome 4 open reading frame 48 |
| chr12_-_58026920 | 7.21 |
ENST00000550764.1
ENST00000551220.1 |
B4GALNT1
|
beta-1,4-N-acetyl-galactosaminyl transferase 1 |
| chr5_+_175298674 | 7.20 |
ENST00000514150.1
|
CPLX2
|
complexin 2 |
| chr6_+_127439749 | 7.19 |
ENST00000356698.4
|
RSPO3
|
R-spondin 3 |
| chr14_-_21566731 | 7.18 |
ENST00000360947.3
|
ZNF219
|
zinc finger protein 219 |
| chr11_+_2923423 | 7.15 |
ENST00000312221.5
|
SLC22A18
|
solute carrier family 22, member 18 |
| chr22_-_22901477 | 7.14 |
ENST00000420709.1
ENST00000398741.1 ENST00000405655.3 |
PRAME
|
preferentially expressed antigen in melanoma |
| chr22_-_22901636 | 7.12 |
ENST00000406503.1
ENST00000439106.1 ENST00000402697.1 ENST00000543184.1 ENST00000398743.2 |
PRAME
|
preferentially expressed antigen in melanoma |
| chr12_+_58005204 | 7.10 |
ENST00000286494.4
|
ARHGEF25
|
Rho guanine nucleotide exchange factor (GEF) 25 |
| chr19_+_54694119 | 7.10 |
ENST00000456872.1
ENST00000302937.4 ENST00000429671.2 |
TSEN34
|
TSEN34 tRNA splicing endonuclease subunit |
| chr7_-_108096822 | 7.07 |
ENST00000379028.3
ENST00000413765.2 ENST00000379022.4 |
NRCAM
|
neuronal cell adhesion molecule |
| chr12_+_105724613 | 7.06 |
ENST00000549934.2
|
C12orf75
|
chromosome 12 open reading frame 75 |
| chr16_+_838614 | 7.03 |
ENST00000262315.9
ENST00000455171.2 |
CHTF18
|
CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae) |
| chr2_-_239148599 | 6.97 |
ENST00000409182.1
ENST00000409002.3 ENST00000450098.1 ENST00000409356.1 ENST00000409160.3 ENST00000409574.1 ENST00000272937.5 |
HES6
|
hes family bHLH transcription factor 6 |
| chr4_+_2043777 | 6.96 |
ENST00000409860.1
|
C4orf48
|
chromosome 4 open reading frame 48 |
| chr9_+_6645887 | 6.89 |
ENST00000413145.1
|
RP11-390F4.6
|
RP11-390F4.6 |
| chr11_+_66742742 | 6.88 |
ENST00000308963.4
|
C11orf86
|
chromosome 11 open reading frame 86 |
| chr2_+_11295498 | 6.76 |
ENST00000295083.3
ENST00000441908.2 |
PQLC3
|
PQ loop repeat containing 3 |
| chr20_+_4129426 | 6.75 |
ENST00000339123.6
ENST00000305958.4 ENST00000278795.3 |
SMOX
|
spermine oxidase |
| chr7_+_36192855 | 6.71 |
ENST00000534978.1
|
EEPD1
|
endonuclease/exonuclease/phosphatase family domain containing 1 |
| chr11_+_842808 | 6.71 |
ENST00000397397.2
ENST00000397411.2 ENST00000397396.1 |
TSPAN4
|
tetraspanin 4 |
| chr5_+_1008910 | 6.71 |
ENST00000296849.5
ENST00000274150.4 ENST00000537972.1 |
NKD2
|
naked cuticle homolog 2 (Drosophila) |
| chr21_+_38071430 | 6.70 |
ENST00000290399.6
|
SIM2
|
single-minded family bHLH transcription factor 2 |
| chr5_+_176513868 | 6.68 |
ENST00000292408.4
|
FGFR4
|
fibroblast growth factor receptor 4 |
| chr17_+_17206635 | 6.63 |
ENST00000389022.4
|
NT5M
|
5',3'-nucleotidase, mitochondrial |
| chr19_+_6373482 | 6.62 |
ENST00000596657.1
|
ALKBH7
|
alkB, alkylation repair homolog 7 (E. coli) |
| chr9_+_97767235 | 6.55 |
ENST00000445181.1
|
C9orf3
|
chromosome 9 open reading frame 3 |
| chr21_+_47518011 | 6.54 |
ENST00000300527.4
ENST00000357838.4 ENST00000310645.5 |
COL6A2
|
collagen, type VI, alpha 2 |
| chr11_-_6440283 | 6.54 |
ENST00000299402.6
ENST00000609360.1 ENST00000389906.2 ENST00000532020.2 |
APBB1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
| chr15_-_65067773 | 6.52 |
ENST00000300069.4
|
RBPMS2
|
RNA binding protein with multiple splicing 2 |
| chr16_-_1821721 | 6.51 |
ENST00000219302.3
|
NME3
|
NME/NM23 nucleoside diphosphate kinase 3 |
| chr2_-_45165994 | 6.48 |
ENST00000444871.2
|
RP11-89K21.1
|
RP11-89K21.1 |
| chr16_-_54962704 | 6.47 |
ENST00000502066.2
ENST00000560912.1 ENST00000558952.1 |
CRNDE
|
colorectal neoplasia differentially expressed (non-protein coding) |
| chr16_-_57836321 | 6.38 |
ENST00000569112.1
ENST00000562311.1 ENST00000445690.2 ENST00000379655.4 |
KIFC3
|
kinesin family member C3 |
| chr11_-_560703 | 6.36 |
ENST00000441853.1
ENST00000329451.3 |
C11orf35
|
chromosome 11 open reading frame 35 |
| chr20_-_4804244 | 6.36 |
ENST00000379400.3
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2 |
| chr11_+_71934962 | 6.35 |
ENST00000543234.1
|
INPPL1
|
inositol polyphosphate phosphatase-like 1 |
| chr22_-_37415475 | 6.33 |
ENST00000403892.3
ENST00000249042.3 ENST00000438203.1 |
TST
|
thiosulfate sulfurtransferase (rhodanese) |
| chrX_-_153707246 | 6.33 |
ENST00000407062.1
|
LAGE3
|
L antigen family, member 3 |
| chr8_-_145691031 | 6.30 |
ENST00000424149.2
ENST00000530637.1 ENST00000306145.5 |
CYHR1
|
cysteine/histidine-rich 1 |
| chr17_+_43299241 | 6.28 |
ENST00000328118.3
|
FMNL1
|
formin-like 1 |
| chr20_+_61867235 | 6.27 |
ENST00000342412.6
ENST00000217169.3 |
BIRC7
|
baculoviral IAP repeat containing 7 |
| chr17_+_30593195 | 6.26 |
ENST00000431505.2
ENST00000269051.4 ENST00000538145.1 |
RHBDL3
|
rhomboid, veinlet-like 3 (Drosophila) |
| chr19_+_35491330 | 6.26 |
ENST00000411896.2
ENST00000424536.2 |
GRAMD1A
|
GRAM domain containing 1A |
| chr17_-_46724186 | 6.26 |
ENST00000433510.2
|
RP11-357H14.17
|
RP11-357H14.17 |
| chr2_+_26395939 | 6.26 |
ENST00000401533.2
|
GAREML
|
GRB2 associated, regulator of MAPK1-like |
| chr10_+_30723045 | 6.21 |
ENST00000542547.1
ENST00000415139.1 |
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8 |
| chr12_+_3068466 | 6.19 |
ENST00000358409.2
|
TEAD4
|
TEA domain family member 4 |
| chr7_-_75368248 | 6.19 |
ENST00000434438.2
ENST00000336926.6 |
HIP1
|
huntingtin interacting protein 1 |
| chr12_-_58026451 | 6.18 |
ENST00000552350.1
ENST00000548888.1 |
B4GALNT1
|
beta-1,4-N-acetyl-galactosaminyl transferase 1 |
| chr7_-_73256838 | 6.17 |
ENST00000297873.4
|
WBSCR27
|
Williams Beuren syndrome chromosome region 27 |
| chr7_-_156803329 | 6.16 |
ENST00000252971.6
|
MNX1
|
motor neuron and pancreas homeobox 1 |
| chr1_-_935361 | 6.16 |
ENST00000484667.2
|
HES4
|
hes family bHLH transcription factor 4 |
| chr11_-_417388 | 6.15 |
ENST00000332725.3
|
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
| chr2_-_234763147 | 6.13 |
ENST00000411486.2
ENST00000432087.1 ENST00000441687.1 ENST00000414924.1 |
HJURP
|
Holliday junction recognition protein |
| chr8_-_145669791 | 6.13 |
ENST00000409379.3
|
TONSL
|
tonsoku-like, DNA repair protein |
| chr19_+_47778119 | 6.12 |
ENST00000552360.2
|
PRR24
|
proline rich 24 |
| chr11_+_2923619 | 6.12 |
ENST00000380574.1
|
SLC22A18
|
solute carrier family 22, member 18 |
| chr2_-_234763105 | 6.12 |
ENST00000454020.1
|
HJURP
|
Holliday junction recognition protein |
| chr9_+_95858485 | 6.12 |
ENST00000375464.2
|
C9orf89
|
chromosome 9 open reading frame 89 |
| chr6_-_30710447 | 6.09 |
ENST00000456573.2
|
FLOT1
|
flotillin 1 |
| chr15_+_69591235 | 6.07 |
ENST00000395407.2
ENST00000558684.1 |
PAQR5
|
progestin and adipoQ receptor family member V |
| chr19_-_10024496 | 6.06 |
ENST00000593091.1
|
OLFM2
|
olfactomedin 2 |
| chr17_+_80376194 | 6.05 |
ENST00000337014.6
|
HEXDC
|
hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing |
| chr9_+_86238016 | 6.03 |
ENST00000530832.1
ENST00000405990.3 ENST00000376417.4 ENST00000376419.4 |
IDNK
|
idnK, gluconokinase homolog (E. coli) |
| chr11_-_17410869 | 6.02 |
ENST00000528731.1
|
KCNJ11
|
potassium inwardly-rectifying channel, subfamily J, member 11 |
| chr19_-_47922373 | 6.02 |
ENST00000559524.1
ENST00000557833.1 ENST00000558555.1 ENST00000561293.1 ENST00000441740.2 |
MEIS3
|
Meis homeobox 3 |
| chrX_-_152736013 | 6.02 |
ENST00000330912.2
ENST00000338525.2 ENST00000334497.2 ENST00000370232.1 ENST00000370212.3 ENST00000370211.4 |
TREX2
HAUS7
|
three prime repair exonuclease 2 HAUS augmin-like complex, subunit 7 |
| chr17_-_41910505 | 6.01 |
ENST00000398389.4
|
MPP3
|
membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3) |
| chr9_+_139560197 | 5.99 |
ENST00000371698.3
|
EGFL7
|
EGF-like-domain, multiple 7 |
| chr11_-_65308082 | 5.96 |
ENST00000532661.1
|
LTBP3
|
latent transforming growth factor beta binding protein 3 |
| chr19_+_55795493 | 5.95 |
ENST00000309383.1
|
BRSK1
|
BR serine/threonine kinase 1 |
| chr17_+_74864476 | 5.92 |
ENST00000301618.4
ENST00000569840.2 |
MGAT5B
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B |
| chr19_-_55658650 | 5.92 |
ENST00000589226.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr7_-_108096765 | 5.91 |
ENST00000379024.4
ENST00000351718.4 |
NRCAM
|
neuronal cell adhesion molecule |
| chr13_-_110438914 | 5.90 |
ENST00000375856.3
|
IRS2
|
insulin receptor substrate 2 |
| chr2_+_120189422 | 5.89 |
ENST00000306406.4
|
TMEM37
|
transmembrane protein 37 |
| chr16_-_1429674 | 5.88 |
ENST00000403703.1
ENST00000397464.1 ENST00000402641.2 |
UNKL
|
unkempt family zinc finger-like |
| chr17_-_73761222 | 5.86 |
ENST00000437911.1
ENST00000225614.2 |
GALK1
|
galactokinase 1 |
| chr17_+_27895609 | 5.85 |
ENST00000581411.2
ENST00000301057.7 |
TP53I13
|
tumor protein p53 inducible protein 13 |
| chr17_-_53499218 | 5.84 |
ENST00000571578.1
|
MMD
|
monocyte to macrophage differentiation-associated |
| chr16_-_2185899 | 5.82 |
ENST00000262304.4
ENST00000423118.1 |
PKD1
|
polycystic kidney disease 1 (autosomal dominant) |
| chr2_+_27309605 | 5.81 |
ENST00000260599.6
ENST00000260598.5 ENST00000429697.1 |
KHK
|
ketohexokinase (fructokinase) |
| chr19_+_48824711 | 5.79 |
ENST00000599704.1
|
EMP3
|
epithelial membrane protein 3 |
| chr19_-_47922750 | 5.78 |
ENST00000331559.5
|
MEIS3
|
Meis homeobox 3 |
| chr16_-_1020954 | 5.77 |
ENST00000543238.1
ENST00000539379.1 ENST00000399843.2 ENST00000262301.11 |
LMF1
|
lipase maturation factor 1 |
| chr9_-_139581848 | 5.76 |
ENST00000538402.1
ENST00000371694.3 |
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
| chr14_-_53417732 | 5.74 |
ENST00000399304.3
ENST00000395631.2 ENST00000341590.3 ENST00000343279.4 |
FERMT2
|
fermitin family member 2 |
| chr20_-_52790055 | 5.73 |
ENST00000395955.3
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1 |
| chr11_-_67397371 | 5.72 |
ENST00000376693.2
ENST00000301490.4 |
NUDT8
|
nudix (nucleoside diphosphate linked moiety X)-type motif 8 |
| chr14_-_65439132 | 5.71 |
ENST00000533601.2
|
RAB15
|
RAB15, member RAS oncogene family |
| chrX_+_198129 | 5.71 |
ENST00000381663.3
|
PLCXD1
|
phosphatidylinositol-specific phospholipase C, X domain containing 1 |
| chr16_+_88519669 | 5.68 |
ENST00000319555.3
|
ZFPM1
|
zinc finger protein, FOG family member 1 |
| chr2_+_11295624 | 5.66 |
ENST00000402361.1
ENST00000428481.1 |
PQLC3
|
PQ loop repeat containing 3 |
| chr8_-_145742862 | 5.63 |
ENST00000524998.1
|
RECQL4
|
RecQ protein-like 4 |
| chr20_+_3026591 | 5.62 |
ENST00000380325.3
|
MRPS26
|
mitochondrial ribosomal protein S26 |
| chr7_-_134143841 | 5.60 |
ENST00000285930.4
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase) |
| chr9_-_86432547 | 5.60 |
ENST00000376365.3
ENST00000376371.2 |
GKAP1
|
G kinase anchoring protein 1 |
| chr19_+_34287174 | 5.59 |
ENST00000587559.1
ENST00000588637.1 |
KCTD15
|
potassium channel tetramerization domain containing 15 |
| chr11_+_44748361 | 5.58 |
ENST00000533202.1
ENST00000533080.1 ENST00000520358.2 ENST00000520999.2 |
TSPAN18
|
tetraspanin 18 |
| chr9_-_139965000 | 5.57 |
ENST00000409687.3
|
SAPCD2
|
suppressor APC domain containing 2 |
| chr19_+_45417921 | 5.57 |
ENST00000252491.4
ENST00000592885.1 ENST00000589781.1 |
APOC1
|
apolipoprotein C-I |
| chr9_+_137979506 | 5.57 |
ENST00000539529.1
ENST00000392991.4 ENST00000371793.3 |
OLFM1
|
olfactomedin 1 |
| chr20_+_388791 | 5.57 |
ENST00000441733.1
ENST00000353660.3 |
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1 |
| chr7_+_128431444 | 5.55 |
ENST00000459946.1
ENST00000378685.4 ENST00000464832.1 ENST00000472049.1 ENST00000488925.1 |
CCDC136
|
coiled-coil domain containing 136 |
| chr19_-_10047219 | 5.54 |
ENST00000264833.4
|
OLFM2
|
olfactomedin 2 |
| chr17_-_43045439 | 5.54 |
ENST00000253407.3
|
C1QL1
|
complement component 1, q subcomponent-like 1 |
| chr1_-_3528034 | 5.54 |
ENST00000356575.4
|
MEGF6
|
multiple EGF-like-domains 6 |
| chr8_-_38325219 | 5.54 |
ENST00000533668.1
ENST00000413133.2 ENST00000397108.4 ENST00000526742.1 ENST00000525001.1 ENST00000425967.3 ENST00000529552.1 ENST00000397113.2 |
FGFR1
|
fibroblast growth factor receptor 1 |
| chr11_-_67771513 | 5.54 |
ENST00000227471.2
|
UNC93B1
|
unc-93 homolog B1 (C. elegans) |
| chr11_+_2923499 | 5.53 |
ENST00000449793.2
|
SLC22A18
|
solute carrier family 22, member 18 |
| chr11_+_61520075 | 5.53 |
ENST00000278836.5
|
MYRF
|
myelin regulatory factor |
| chr14_+_103589789 | 5.52 |
ENST00000558056.1
ENST00000560869.1 |
TNFAIP2
|
tumor necrosis factor, alpha-induced protein 2 |
| chr22_+_18893736 | 5.52 |
ENST00000331444.6
|
DGCR6
|
DiGeorge syndrome critical region gene 6 |
| chr15_+_78857849 | 5.51 |
ENST00000299565.5
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal) |
| chr19_+_38893809 | 5.50 |
ENST00000589408.1
|
FAM98C
|
family with sequence similarity 98, member C |
| chr16_+_770975 | 5.50 |
ENST00000569529.1
ENST00000564000.1 ENST00000219535.3 |
FAM173A
|
family with sequence similarity 173, member A |
| chr9_-_139581875 | 5.48 |
ENST00000371696.2
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
| chr17_+_77020325 | 5.48 |
ENST00000311661.4
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
| chr9_+_140445651 | 5.45 |
ENST00000371443.5
|
MRPL41
|
mitochondrial ribosomal protein L41 |
| chrX_+_152240819 | 5.45 |
ENST00000421798.3
ENST00000535416.1 |
PNMA6C
PNMA6A
|
paraneoplastic Ma antigen family member 6C paraneoplastic Ma antigen family member 6A |
| chr19_+_4304585 | 5.45 |
ENST00000221856.6
|
FSD1
|
fibronectin type III and SPRY domain containing 1 |
Network of associatons between targets according to the STRING database.
First level regulatory network of SP3
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.8 | 34.7 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 4.9 | 19.6 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 4.9 | 9.7 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 4.6 | 23.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 4.1 | 20.3 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 3.9 | 11.7 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 3.7 | 11.1 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 3.6 | 10.8 | GO:2000830 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 3.6 | 10.8 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
| 3.6 | 14.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 3.3 | 10.0 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 3.3 | 13.2 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 3.2 | 15.9 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 3.1 | 12.3 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 3.0 | 27.4 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 3.0 | 12.2 | GO:0019056 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 3.0 | 18.3 | GO:0015878 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 3.0 | 3.0 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 3.0 | 15.0 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 2.9 | 8.8 | GO:0043181 | vacuolar sequestering(GO:0043181) |
| 2.9 | 20.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 2.9 | 17.4 | GO:0070981 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 2.9 | 8.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 2.9 | 8.6 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 2.8 | 8.5 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 2.8 | 13.9 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 2.8 | 8.3 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 2.8 | 8.3 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 2.7 | 16.3 | GO:1903412 | response to bile acid(GO:1903412) |
| 2.6 | 20.9 | GO:0046618 | drug export(GO:0046618) |
| 2.6 | 10.4 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 2.6 | 10.3 | GO:0060032 | notochord regression(GO:0060032) |
| 2.5 | 5.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 2.5 | 10.1 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
| 2.5 | 2.5 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 2.5 | 7.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 2.5 | 9.8 | GO:0006272 | leading strand elongation(GO:0006272) |
| 2.4 | 12.2 | GO:0015862 | uridine transport(GO:0015862) |
| 2.4 | 7.3 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 2.4 | 21.8 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 2.4 | 12.1 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 2.4 | 9.6 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 2.4 | 26.3 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 2.4 | 7.1 | GO:0031662 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 2.4 | 19.0 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 2.3 | 25.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 2.3 | 11.6 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 2.3 | 16.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 2.3 | 6.9 | GO:0046081 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 2.3 | 4.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 2.2 | 6.7 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 2.2 | 8.9 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 2.2 | 11.2 | GO:0060301 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 2.2 | 8.9 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 2.2 | 6.6 | GO:0071423 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 2.2 | 6.6 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 2.2 | 13.0 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 2.1 | 12.8 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 2.1 | 4.2 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 2.1 | 6.3 | GO:0090427 | activation of meiosis(GO:0090427) |
| 2.1 | 16.8 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 2.1 | 12.5 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 2.1 | 12.4 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 2.1 | 8.3 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
| 2.0 | 6.1 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 2.0 | 8.1 | GO:0002432 | granuloma formation(GO:0002432) |
| 2.0 | 4.0 | GO:0072021 | ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) |
| 2.0 | 8.0 | GO:0061743 | motor learning(GO:0061743) |
| 2.0 | 23.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 2.0 | 4.0 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 2.0 | 5.9 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 2.0 | 5.9 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 2.0 | 5.9 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 2.0 | 2.0 | GO:1901420 | regulation of vitamin D receptor signaling pathway(GO:0070562) negative regulation of vitamin D receptor signaling pathway(GO:0070563) regulation of response to alcohol(GO:1901419) negative regulation of response to alcohol(GO:1901420) |
| 1.9 | 23.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 1.9 | 5.8 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 1.9 | 5.8 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 1.9 | 3.8 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 1.9 | 11.4 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 1.9 | 5.7 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 1.8 | 51.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 1.8 | 11.0 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 1.8 | 1.8 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 1.8 | 18.0 | GO:0009111 | vitamin catabolic process(GO:0009111) |
| 1.8 | 1.8 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
| 1.8 | 18.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 1.8 | 7.2 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
| 1.8 | 16.1 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 1.8 | 25.0 | GO:0007144 | female meiosis I(GO:0007144) |
| 1.8 | 1.8 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 1.8 | 7.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 1.8 | 1.8 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 1.8 | 7.1 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 1.8 | 1.8 | GO:0072014 | proximal tubule development(GO:0072014) |
| 1.8 | 5.3 | GO:0100009 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 1.8 | 10.5 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 1.7 | 1.7 | GO:0046543 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
| 1.7 | 6.9 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 1.7 | 5.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.7 | 17.1 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 1.7 | 13.6 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 1.7 | 5.1 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 1.7 | 5.1 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 1.7 | 3.4 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
| 1.7 | 5.0 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 1.7 | 1.7 | GO:0060214 | endocardium formation(GO:0060214) |
| 1.7 | 5.0 | GO:0090108 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 1.6 | 8.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 1.6 | 4.9 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 1.6 | 4.9 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 1.6 | 8.2 | GO:1902228 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 1.6 | 1.6 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 1.6 | 8.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 1.6 | 8.2 | GO:0032218 | riboflavin transport(GO:0032218) |
| 1.6 | 9.8 | GO:0051958 | methotrexate transport(GO:0051958) |
| 1.6 | 3.2 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 1.6 | 6.5 | GO:0035565 | regulation of pronephros size(GO:0035565) |
| 1.6 | 25.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 1.6 | 22.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 1.6 | 11.2 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 1.6 | 4.8 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 1.6 | 4.8 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 1.6 | 4.7 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 1.6 | 4.7 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
| 1.6 | 4.7 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 1.6 | 4.7 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 1.6 | 7.8 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 1.5 | 6.2 | GO:2000230 | response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 1.5 | 13.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 1.5 | 4.5 | GO:0031427 | response to methotrexate(GO:0031427) |
| 1.5 | 4.5 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 1.5 | 1.5 | GO:0044849 | estrous cycle(GO:0044849) |
| 1.5 | 4.4 | GO:2001113 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
| 1.5 | 19.0 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 1.5 | 2.9 | GO:0070166 | enamel mineralization(GO:0070166) |
| 1.4 | 5.8 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 1.4 | 8.6 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 1.4 | 5.8 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 1.4 | 1.4 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
| 1.4 | 10.0 | GO:0060356 | leucine import(GO:0060356) |
| 1.4 | 5.7 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 1.4 | 2.8 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
| 1.4 | 2.8 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 1.4 | 15.5 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 1.4 | 5.6 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 1.4 | 5.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 1.4 | 4.2 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 1.4 | 4.2 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 1.4 | 5.5 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
| 1.4 | 4.2 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
| 1.4 | 4.1 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 1.4 | 8.3 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 1.4 | 9.6 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 1.4 | 1.4 | GO:0072098 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
| 1.4 | 2.7 | GO:0005997 | xylulose metabolic process(GO:0005997) |
| 1.4 | 5.4 | GO:1905045 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 1.4 | 5.4 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 1.4 | 2.7 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 1.4 | 9.5 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 1.4 | 6.8 | GO:1903400 | L-arginine transmembrane transport(GO:1903400) |
| 1.4 | 9.5 | GO:0042262 | DNA protection(GO:0042262) |
| 1.3 | 13.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 1.3 | 8.1 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 1.3 | 4.0 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
| 1.3 | 12.0 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 1.3 | 4.0 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 1.3 | 21.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 1.3 | 1.3 | GO:0060967 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) negative regulation of gene silencing(GO:0060969) |
| 1.3 | 5.3 | GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 1.3 | 9.3 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 1.3 | 13.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 1.3 | 4.0 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 1.3 | 1.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 1.3 | 10.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 1.3 | 5.2 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 1.3 | 2.6 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 1.3 | 10.3 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 1.3 | 6.4 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 1.3 | 6.4 | GO:0003285 | septum secundum development(GO:0003285) |
| 1.3 | 5.1 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 1.3 | 1.3 | GO:0003274 | endocardial cushion fusion(GO:0003274) |
| 1.3 | 6.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 1.3 | 5.0 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 1.3 | 3.8 | GO:0019860 | uracil metabolic process(GO:0019860) |
| 1.2 | 3.7 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 1.2 | 5.0 | GO:0090299 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 1.2 | 1.2 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 1.2 | 22.2 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 1.2 | 1.2 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
| 1.2 | 18.3 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 1.2 | 2.4 | GO:0000732 | strand displacement(GO:0000732) |
| 1.2 | 4.9 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
| 1.2 | 3.6 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 1.2 | 4.8 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 1.2 | 6.0 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 1.2 | 10.7 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
| 1.2 | 3.6 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 1.2 | 5.9 | GO:0031296 | B cell costimulation(GO:0031296) |
| 1.2 | 1.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
| 1.2 | 4.7 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 1.2 | 4.7 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 1.2 | 2.3 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 1.2 | 17.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 1.2 | 15.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 1.2 | 3.5 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 1.1 | 4.6 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
| 1.1 | 1.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 1.1 | 4.6 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 1.1 | 18.3 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 1.1 | 3.4 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 1.1 | 4.6 | GO:0032811 | regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) epinephrine secretion(GO:0048242) |
| 1.1 | 6.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 1.1 | 2.2 | GO:0007412 | axon target recognition(GO:0007412) |
| 1.1 | 14.6 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 1.1 | 13.4 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 1.1 | 3.4 | GO:2000397 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 1.1 | 3.3 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
| 1.1 | 14.4 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 1.1 | 1.1 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 1.1 | 3.3 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 1.1 | 5.5 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 1.1 | 3.3 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 1.1 | 5.5 | GO:0036343 | psychomotor behavior(GO:0036343) |
| 1.1 | 2.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 1.1 | 5.5 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 1.1 | 2.2 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
| 1.1 | 8.7 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
| 1.1 | 6.5 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 1.1 | 8.6 | GO:0006083 | acetate metabolic process(GO:0006083) |
| 1.1 | 4.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 1.1 | 3.2 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
| 1.1 | 3.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 1.1 | 3.2 | GO:0097187 | dentinogenesis(GO:0097187) |
| 1.1 | 7.4 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 1.1 | 1.1 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 1.1 | 3.2 | GO:0045720 | negative regulation of integrin biosynthetic process(GO:0045720) |
| 1.1 | 3.2 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
| 1.0 | 4.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 1.0 | 8.4 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 1.0 | 3.1 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 1.0 | 3.1 | GO:0043602 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
| 1.0 | 7.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 1.0 | 1.0 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 1.0 | 6.2 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 1.0 | 5.2 | GO:1901536 | negative regulation of DNA demethylation(GO:1901536) |
| 1.0 | 3.1 | GO:0019516 | lactate oxidation(GO:0019516) |
| 1.0 | 8.2 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 1.0 | 2.0 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
| 1.0 | 5.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
| 1.0 | 3.0 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 1.0 | 1.0 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 1.0 | 13.0 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 1.0 | 5.0 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
| 1.0 | 3.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 1.0 | 3.0 | GO:0072179 | nephric duct formation(GO:0072179) |
| 1.0 | 5.9 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 1.0 | 3.9 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 1.0 | 3.0 | GO:1902568 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 1.0 | 4.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 1.0 | 2.9 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 1.0 | 12.7 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 1.0 | 2.9 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
| 1.0 | 16.6 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
| 1.0 | 1.0 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
| 1.0 | 6.8 | GO:0071486 | cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 1.0 | 1.9 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
| 1.0 | 4.8 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 1.0 | 1.9 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.9 | 3.8 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.9 | 0.9 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.9 | 3.8 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.9 | 3.8 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.9 | 2.8 | GO:0019401 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.9 | 0.9 | GO:0021769 | orbitofrontal cortex development(GO:0021769) |
| 0.9 | 2.8 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.9 | 1.9 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.9 | 1.9 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 0.9 | 21.3 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.9 | 7.4 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.9 | 2.8 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
| 0.9 | 5.5 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.9 | 15.6 | GO:0015886 | heme transport(GO:0015886) |
| 0.9 | 9.2 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
| 0.9 | 11.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.9 | 5.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 0.9 | 2.7 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.9 | 2.7 | GO:0070512 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 0.9 | 5.4 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.9 | 7.2 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.9 | 0.9 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
| 0.9 | 17.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
| 0.9 | 2.7 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.9 | 7.2 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.9 | 2.7 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
| 0.9 | 6.3 | GO:0019075 | virus maturation(GO:0019075) |
| 0.9 | 0.9 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.9 | 0.9 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.9 | 4.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.9 | 2.7 | GO:0018194 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.9 | 0.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.9 | 4.5 | GO:1901091 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.9 | 17.9 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.9 | 0.9 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.9 | 2.7 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.9 | 11.5 | GO:0030091 | protein repair(GO:0030091) |
| 0.9 | 1.8 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.9 | 2.6 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.9 | 35.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.9 | 9.6 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.9 | 3.5 | GO:0035668 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.9 | 3.5 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.9 | 4.4 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 0.9 | 4.3 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.9 | 1.7 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.9 | 4.3 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.9 | 0.9 | GO:1903401 | L-lysine transmembrane transport(GO:1903401) |
| 0.9 | 3.4 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.9 | 1.7 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.9 | 2.6 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
| 0.8 | 6.8 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.8 | 0.8 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.8 | 11.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.8 | 0.8 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.8 | 5.9 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.8 | 3.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.8 | 2.5 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
| 0.8 | 5.0 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.8 | 1.7 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) serotonergic neuron axon guidance(GO:0036515) planar cell polarity pathway involved in axon guidance(GO:1904938) |
| 0.8 | 1.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.8 | 0.8 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
| 0.8 | 4.1 | GO:0015822 | mitochondrial ornithine transport(GO:0000066) ornithine transport(GO:0015822) |
| 0.8 | 3.3 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.8 | 1.6 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.8 | 7.3 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.8 | 0.8 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.8 | 0.8 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.8 | 12.1 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.8 | 3.2 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.8 | 2.4 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
| 0.8 | 0.8 | GO:0032425 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
| 0.8 | 1.6 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.8 | 4.0 | GO:0007135 | meiosis II(GO:0007135) |
| 0.8 | 2.4 | GO:0010159 | specification of organ position(GO:0010159) |
| 0.8 | 7.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.8 | 0.8 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
| 0.8 | 2.4 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.8 | 8.7 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.8 | 4.8 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.8 | 4.8 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
| 0.8 | 4.7 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.8 | 3.9 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.8 | 3.1 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.8 | 8.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.8 | 2.3 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.8 | 6.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.8 | 3.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.8 | 4.6 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
| 0.8 | 3.8 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.8 | 33.0 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
| 0.8 | 0.8 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.8 | 8.4 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.8 | 1.5 | GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.8 | 3.0 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.8 | 2.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.8 | 3.8 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.8 | 2.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.8 | 6.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.8 | 0.8 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.8 | 4.5 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.8 | 3.8 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.7 | 3.7 | GO:0030222 | eosinophil differentiation(GO:0030222) |
| 0.7 | 1.5 | GO:0060197 | cloacal septation(GO:0060197) |
| 0.7 | 10.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.7 | 3.7 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.7 | 3.0 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.7 | 0.7 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 0.7 | 2.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.7 | 6.6 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
| 0.7 | 0.7 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
| 0.7 | 1.5 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.7 | 0.7 | GO:0035864 | response to potassium ion(GO:0035864) |
| 0.7 | 3.6 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.7 | 5.8 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.7 | 1.5 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
| 0.7 | 5.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
| 0.7 | 3.6 | GO:0046677 | response to antibiotic(GO:0046677) |
| 0.7 | 2.2 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
| 0.7 | 5.7 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.7 | 2.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.7 | 13.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.7 | 0.7 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.7 | 2.9 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
| 0.7 | 15.6 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.7 | 0.7 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
| 0.7 | 2.8 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.7 | 7.0 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.7 | 3.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.7 | 0.7 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.7 | 15.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.7 | 3.5 | GO:0051292 | nuclear pore organization(GO:0006999) nuclear pore complex assembly(GO:0051292) |
| 0.7 | 5.6 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.7 | 20.1 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.7 | 2.8 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.7 | 2.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.7 | 6.2 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.7 | 2.8 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.7 | 2.1 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.7 | 2.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.7 | 18.4 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.7 | 2.7 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.7 | 15.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.7 | 2.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.7 | 2.0 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.7 | 9.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.7 | 3.4 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 0.7 | 0.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.7 | 4.1 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.7 | 9.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.7 | 3.4 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.7 | 4.7 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.7 | 5.4 | GO:0032310 | prostaglandin secretion(GO:0032310) |
| 0.7 | 4.7 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.7 | 0.7 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.7 | 0.7 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.7 | 2.0 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.7 | 1.3 | GO:0061074 | regulation of neural retina development(GO:0061074) |
| 0.7 | 1.3 | GO:0048369 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) |
| 0.7 | 4.7 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.7 | 0.7 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.7 | 4.0 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) dTTP metabolic process(GO:0046075) |
| 0.7 | 2.0 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.7 | 0.7 | GO:0034759 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
| 0.7 | 2.0 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 0.7 | 2.0 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
| 0.7 | 0.7 | GO:0035989 | tendon development(GO:0035989) |
| 0.7 | 3.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.7 | 5.9 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.6 | 3.9 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.6 | 2.6 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.6 | 3.9 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.6 | 0.6 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.6 | 10.9 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.6 | 7.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.6 | 2.6 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
| 0.6 | 1.9 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
| 0.6 | 5.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.6 | 3.8 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.6 | 2.5 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.6 | 1.9 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.6 | 3.2 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
| 0.6 | 2.5 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
| 0.6 | 1.9 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.6 | 2.5 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.6 | 0.6 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
| 0.6 | 2.5 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.6 | 0.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 0.6 | 1.9 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 0.6 | 11.8 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.6 | 7.4 | GO:0009304 | tRNA transcription(GO:0009304) |
| 0.6 | 11.1 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.6 | 1.8 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.6 | 5.5 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.6 | 1.8 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.6 | 1.8 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
| 0.6 | 1.2 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.6 | 0.6 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.6 | 0.6 | GO:0072197 | ureter morphogenesis(GO:0072197) |
| 0.6 | 8.4 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.6 | 3.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.6 | 1.8 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.6 | 1.8 | GO:1901207 | regulation of heart looping(GO:1901207) |
| 0.6 | 2.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.6 | 2.4 | GO:0060426 | lung vasculature development(GO:0060426) |
| 0.6 | 2.4 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.6 | 7.1 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 0.6 | 1.2 | GO:1904385 | cellular response to angiotensin(GO:1904385) |
| 0.6 | 3.5 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.6 | 20.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.6 | 3.5 | GO:1901523 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.6 | 9.4 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
| 0.6 | 11.1 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.6 | 0.6 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.6 | 2.3 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.6 | 1.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 0.6 | 1.2 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.6 | 4.7 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 0.6 | 2.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.6 | 2.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.6 | 5.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.6 | 2.9 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
| 0.6 | 3.5 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.6 | 0.6 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.6 | 4.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.6 | 12.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.6 | 1.7 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.6 | 1.7 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.6 | 1.1 | GO:0035787 | cell migration involved in kidney development(GO:0035787) |
| 0.6 | 3.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
| 0.6 | 15.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.6 | 3.4 | GO:0015888 | thiamine transport(GO:0015888) |
| 0.6 | 8.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.6 | 1.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.6 | 12.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.6 | 2.8 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.6 | 0.6 | GO:0060037 | pharyngeal system development(GO:0060037) |
| 0.6 | 1.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.6 | 2.2 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.6 | 1.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.6 | 3.9 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.6 | 4.5 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.6 | 1.7 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.6 | 0.6 | GO:0033058 | directional locomotion(GO:0033058) |
| 0.6 | 13.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.6 | 5.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.6 | 0.6 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.5 | 4.4 | GO:0050893 | sensory processing(GO:0050893) |
| 0.5 | 1.1 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
| 0.5 | 0.5 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.5 | 2.2 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.5 | 2.2 | GO:0015684 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
| 0.5 | 2.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.5 | 1.6 | GO:0051685 | maintenance of ER location(GO:0051685) |
| 0.5 | 2.2 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.5 | 1.6 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.5 | 5.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.5 | 0.5 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.5 | 2.7 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.5 | 2.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.5 | 9.0 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
| 0.5 | 2.1 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.5 | 1.1 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.5 | 4.2 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.5 | 1.6 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.5 | 4.2 | GO:0044211 | CTP salvage(GO:0044211) |
| 0.5 | 4.8 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.5 | 0.5 | GO:0030851 | granulocyte differentiation(GO:0030851) |
| 0.5 | 8.4 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.5 | 1.1 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.5 | 1.6 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
| 0.5 | 1.6 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.5 | 1.0 | GO:0035712 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.5 | 3.1 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.5 | 3.1 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) |
| 0.5 | 6.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.5 | 2.1 | GO:0072183 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of nephron tubule epithelial cell differentiation(GO:0072183) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) negative regulation of epithelial cell differentiation involved in kidney development(GO:2000697) |
| 0.5 | 15.9 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.5 | 5.7 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.5 | 1.0 | GO:2001176 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.5 | 4.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.5 | 0.5 | GO:0036309 | protein localization to M-band(GO:0036309) |
| 0.5 | 6.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.5 | 1.5 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.5 | 2.6 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.5 | 2.0 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.5 | 3.1 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.5 | 1.5 | GO:0060023 | soft palate development(GO:0060023) |
| 0.5 | 6.1 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
| 0.5 | 2.0 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.5 | 1.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.5 | 3.0 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
| 0.5 | 2.5 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
| 0.5 | 0.5 | GO:0001768 | establishment of T cell polarity(GO:0001768) |
| 0.5 | 1.0 | GO:0006203 | dGTP catabolic process(GO:0006203) |
| 0.5 | 2.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.5 | 1.5 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.5 | 3.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.5 | 1.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.5 | 4.5 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.5 | 1.0 | GO:0072249 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.5 | 0.5 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.5 | 7.0 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.5 | 3.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.5 | 1.5 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.5 | 3.5 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
| 0.5 | 3.5 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 0.5 | 6.4 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.5 | 3.9 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.5 | 1.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.5 | 0.5 | GO:0034699 | response to luteinizing hormone(GO:0034699) |
| 0.5 | 1.0 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) activation of protein kinase C activity(GO:1990051) |
| 0.5 | 0.5 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.5 | 1.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
| 0.5 | 3.9 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.5 | 2.0 | GO:0002118 | aggressive behavior(GO:0002118) |
| 0.5 | 3.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
| 0.5 | 5.3 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
| 0.5 | 9.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 | 0.5 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.5 | 36.7 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
| 0.5 | 2.4 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.5 | 1.4 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.5 | 5.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.5 | 1.4 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.5 | 6.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.5 | 1.9 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.5 | 9.5 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.5 | 16.6 | GO:0007094 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
| 0.5 | 11.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.5 | 0.5 | GO:1902616 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.5 | 12.2 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
| 0.5 | 2.4 | GO:0071874 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.5 | 0.9 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.5 | 5.6 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.5 | 2.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.5 | 2.3 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.5 | 0.9 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.5 | 1.4 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.5 | 1.4 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.5 | 0.5 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
| 0.5 | 1.9 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.5 | 6.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.5 | 4.2 | GO:0071316 | cellular response to nicotine(GO:0071316) |
| 0.5 | 10.2 | GO:0015893 | drug transport(GO:0015893) |
| 0.5 | 2.8 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.5 | 0.9 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
| 0.5 | 6.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.5 | 3.7 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.5 | 1.8 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.5 | 0.5 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.5 | 10.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.5 | 3.2 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.4 | 1.3 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.4 | 1.3 | GO:0006524 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.4 | 3.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.4 | 4.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.4 | 14.7 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.4 | 0.9 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.4 | 0.9 | GO:0015827 | tryptophan transport(GO:0015827) |
| 0.4 | 2.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.4 | 3.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.4 | 0.4 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
| 0.4 | 3.9 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.4 | 1.3 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.4 | 6.5 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.4 | 1.3 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.4 | 1.7 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 0.4 | 0.4 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
| 0.4 | 3.9 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.4 | 1.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.4 | 0.9 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 0.4 | 0.9 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 0.4 | 3.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.4 | 4.3 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.4 | 0.4 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.4 | 0.4 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
| 0.4 | 49.7 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
| 0.4 | 0.4 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 0.4 | 3.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.4 | 1.3 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.4 | 0.8 | GO:0002086 | diaphragm contraction(GO:0002086) |
| 0.4 | 2.1 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.4 | 2.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.4 | 2.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.4 | 11.7 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
| 0.4 | 1.7 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.4 | 1.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.4 | 1.2 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
| 0.4 | 2.5 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.4 | 1.7 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.4 | 1.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.4 | 0.8 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.4 | 1.6 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
| 0.4 | 1.6 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.4 | 1.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.4 | 2.8 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.4 | 1.2 | GO:0070426 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.4 | 0.8 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.4 | 2.8 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.4 | 0.4 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.4 | 11.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.4 | 6.8 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.4 | 8.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.4 | 0.8 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 0.4 | 8.0 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.4 | 2.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.4 | 0.8 | GO:0072229 | proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
| 0.4 | 7.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.4 | 1.6 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.4 | 6.3 | GO:0001964 | startle response(GO:0001964) |
| 0.4 | 0.4 | GO:1903762 | positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
| 0.4 | 2.7 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.4 | 1.2 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.4 | 1.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
| 0.4 | 2.3 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.4 | 1.6 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.4 | 36.9 | GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
| 0.4 | 3.5 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.4 | 0.8 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.4 | 1.2 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.4 | 1.5 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.4 | 3.1 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 0.4 | 3.8 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.4 | 5.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.4 | 9.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.4 | 2.7 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.4 | 0.8 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.4 | 1.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.4 | 0.8 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.4 | 0.8 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.4 | 1.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.4 | 0.8 | GO:1901722 | regulation of cell proliferation involved in kidney development(GO:1901722) |
| 0.4 | 2.3 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.4 | 0.4 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.4 | 1.1 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.4 | 4.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.4 | 4.5 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.4 | 0.4 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
| 0.4 | 0.8 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
| 0.4 | 4.9 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.4 | 1.1 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.4 | 4.8 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.4 | 2.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.4 | 1.5 | GO:0045208 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.4 | 1.9 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.4 | 3.3 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.4 | 2.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.4 | 4.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.4 | 0.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.4 | 5.5 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.4 | 0.4 | GO:0090212 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.4 | 1.1 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.4 | 0.4 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
| 0.4 | 8.4 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.4 | 1.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.4 | 9.5 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.4 | 1.8 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.4 | 0.4 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 0.4 | 2.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.4 | 3.3 | GO:0090656 | t-circle formation(GO:0090656) |
| 0.4 | 1.1 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 0.4 | 2.9 | GO:0019748 | secondary metabolic process(GO:0019748) |
| 0.4 | 2.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.4 | 8.6 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.4 | 1.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.4 | 1.1 | GO:0061580 | colon epithelial cell migration(GO:0061580) |
| 0.4 | 1.8 | GO:1901898 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.4 | 0.7 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 0.4 | 5.0 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.4 | 4.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.4 | 7.1 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.4 | 1.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.4 | 1.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.4 | 6.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.3 | 2.4 | GO:0010133 | proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
| 0.3 | 15.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.3 | 1.0 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.3 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.3 | 3.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.3 | 2.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.3 | 3.5 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.3 | 0.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.3 | 0.3 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.3 | 4.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.3 | 1.0 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.3 | 3.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.3 | 2.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 0.3 | 1.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.3 | 30.8 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.3 | 1.7 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.3 | 0.3 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
| 0.3 | 1.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.3 | 1.4 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.3 | 0.7 | GO:0012502 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 0.3 | 1.0 | GO:1900098 | epithelial cell differentiation involved in salivary gland development(GO:0060690) epithelial cell maturation involved in salivary gland development(GO:0060691) regulation of plasma cell differentiation(GO:1900098) positive regulation of plasma cell differentiation(GO:1900100) regulation of lactation(GO:1903487) positive regulation of lactation(GO:1903489) |
| 0.3 | 6.4 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.3 | 1.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.3 | 9.0 | GO:0007625 | grooming behavior(GO:0007625) |
| 0.3 | 1.7 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 0.3 | 0.3 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 0.3 | 0.3 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.3 | 4.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.3 | 0.7 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
| 0.3 | 1.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
| 0.3 | 0.3 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.3 | 2.0 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.3 | 0.7 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.3 | 0.7 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.3 | 1.0 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 0.3 | 2.6 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
| 0.3 | 0.7 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
| 0.3 | 2.6 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.3 | 1.6 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
| 0.3 | 0.6 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
| 0.3 | 8.1 | GO:0030261 | chromosome condensation(GO:0030261) |
| 0.3 | 1.3 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.3 | 1.6 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.3 | 2.9 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.3 | 1.9 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
| 0.3 | 1.6 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.3 | 1.0 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.3 | 1.9 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.3 | 1.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.3 | 2.5 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.3 | 1.9 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.3 | 4.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.3 | 1.6 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.3 | 0.6 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.3 | 0.9 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.3 | 0.9 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
| 0.3 | 0.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.3 | 0.9 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
| 0.3 | 4.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.3 | 0.6 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.3 | 7.4 | GO:0021517 | ventral spinal cord development(GO:0021517) |
| 0.3 | 5.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.3 | 1.5 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.3 | 1.2 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
| 0.3 | 4.6 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.3 | 1.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.3 | 0.6 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.3 | 0.6 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.3 | 0.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
| 0.3 | 0.9 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.3 | 0.3 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.3 | 5.1 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.3 | 1.2 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.3 | 6.3 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.3 | 1.5 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.3 | 0.9 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 0.3 | 1.5 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.3 | 0.6 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.3 | 0.6 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.3 | 1.2 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.3 | 2.9 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.3 | 1.7 | GO:2000193 | positive regulation of icosanoid secretion(GO:0032305) positive regulation of fatty acid transport(GO:2000193) |
| 0.3 | 1.4 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.3 | 0.6 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.3 | 0.3 | GO:0060922 | cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.3 | 2.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.3 | 3.7 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.3 | 5.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.3 | 0.6 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.3 | 1.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.3 | 3.4 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.3 | 0.8 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 0.3 | 0.8 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
| 0.3 | 2.0 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
| 0.3 | 3.9 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.3 | 1.1 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
| 0.3 | 4.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.3 | 0.8 | GO:0050703 | interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
| 0.3 | 0.6 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.3 | 1.7 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.3 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
| 0.3 | 4.4 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.3 | 1.4 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
| 0.3 | 0.8 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
| 0.3 | 9.1 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.3 | 1.6 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 0.3 | 1.4 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.3 | 0.8 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.3 | 0.8 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.3 | 2.2 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.3 | 6.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.3 | 1.6 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
| 0.3 | 0.3 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.3 | 1.9 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
| 0.3 | 1.1 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.3 | 0.8 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
| 0.3 | 0.5 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.3 | 0.8 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.3 | 1.3 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
| 0.3 | 3.2 | GO:1901571 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
| 0.3 | 1.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.3 | 0.8 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.3 | 0.8 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.3 | 1.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.3 | 3.7 | GO:0030238 | male sex determination(GO:0030238) |
| 0.3 | 0.8 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.3 | 0.8 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.3 | 2.1 | GO:1901142 | insulin metabolic process(GO:1901142) |
| 0.3 | 4.2 | GO:0036376 | sodium ion export from cell(GO:0036376) |
| 0.3 | 0.5 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.3 | 1.0 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.3 | 3.1 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.3 | 1.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.3 | 13.5 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.3 | 10.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.3 | 2.6 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.3 | 0.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.3 | 1.0 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 0.3 | 0.8 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
| 0.3 | 1.0 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.3 | 0.8 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.3 | 7.6 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.3 | 4.6 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
| 0.3 | 0.8 | GO:0009648 | photoperiodism(GO:0009648) |
| 0.3 | 1.0 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.3 | 0.8 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
| 0.3 | 0.8 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.3 | 3.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.3 | 0.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.2 | 0.7 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.2 | 0.5 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.2 | 0.5 | GO:0030240 | skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
| 0.2 | 0.2 | GO:0019605 | butyrate metabolic process(GO:0019605) |
| 0.2 | 1.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.2 | 1.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.2 | 1.7 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.2 | 5.6 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.2 | 2.9 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.2 | 1.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.2 | 2.7 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.2 | 12.8 | GO:0061620 | glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) |
| 0.2 | 0.5 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.2 | 1.2 | GO:0001315 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.2 | 6.3 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.2 | 2.2 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.2 | 2.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 | 1.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.2 | 0.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 0.2 | 4.7 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 0.2 | 1.4 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.2 | 1.9 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
| 0.2 | 0.9 | GO:0071462 | cellular response to water deprivation(GO:0042631) cellular response to water stimulus(GO:0071462) |
| 0.2 | 1.6 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
| 0.2 | 0.2 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
| 0.2 | 0.2 | GO:0043379 | memory T cell differentiation(GO:0043379) |
| 0.2 | 0.7 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
| 0.2 | 0.7 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
| 0.2 | 0.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
| 0.2 | 0.5 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.2 | 1.4 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.2 | 1.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.2 | 3.0 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.2 | 0.2 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
| 0.2 | 0.7 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.2 | 1.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.2 | 0.7 | GO:0009206 | purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
| 0.2 | 0.7 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 | 1.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.2 | 2.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.2 | 0.5 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.2 | 2.5 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.2 | 2.2 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
| 0.2 | 0.7 | GO:0001302 | replicative cell aging(GO:0001302) |
| 0.2 | 2.2 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
| 0.2 | 1.8 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.2 | 0.9 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.2 | 0.4 | GO:2001302 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.2 | 0.7 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.2 | 0.7 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 0.2 | 1.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.2 | 0.7 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.2 | 0.2 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
| 0.2 | 0.4 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.2 | 0.9 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.2 | 2.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.2 | 0.4 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.2 | 0.7 | GO:0008216 | spermidine metabolic process(GO:0008216) |
| 0.2 | 0.9 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
| 0.2 | 0.2 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.2 | 0.2 | GO:0044828 | negative regulation by host of viral process(GO:0044793) negative regulation by host of viral genome replication(GO:0044828) |
| 0.2 | 0.9 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
| 0.2 | 3.5 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.2 | 1.5 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
| 0.2 | 0.9 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.2 | 0.2 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
| 0.2 | 0.4 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.2 | 1.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.2 | 3.0 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
| 0.2 | 4.1 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.2 | 0.4 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.2 | 0.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.2 | 0.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.2 | 0.4 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.2 | 3.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.2 | 1.7 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.2 | 0.6 | GO:0090260 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.2 | 1.5 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.2 | 0.4 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.2 | 0.2 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
| 0.2 | 1.9 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.2 | 0.2 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
| 0.2 | 0.8 | GO:0065001 | specification of axis polarity(GO:0065001) |
| 0.2 | 0.8 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.2 | 0.6 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
| 0.2 | 1.6 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
| 0.2 | 2.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.2 | 17.1 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.2 | 0.4 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.2 | 0.6 | GO:1901340 | negative regulation of store-operated calcium channel activity(GO:1901340) |
| 0.2 | 0.2 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.2 | 0.8 | GO:0070672 | response to interleukin-15(GO:0070672) |
| 0.2 | 1.0 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.2 | 2.0 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.2 | 1.2 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.2 | 0.2 | GO:0002663 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
| 0.2 | 1.8 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.2 | 1.8 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
| 0.2 | 1.6 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.2 | 0.6 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.2 | 6.9 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.2 | 4.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.2 | 0.4 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 0.2 | 1.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 | 1.6 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.2 | 0.2 | GO:1902214 | regulation of interleukin-4-mediated signaling pathway(GO:1902214) |
| 0.2 | 2.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.2 | 0.6 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
| 0.2 | 6.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.2 | 0.6 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
| 0.2 | 0.2 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.2 | 3.3 | GO:0043578 | nuclear matrix organization(GO:0043578) |
| 0.2 | 1.9 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.2 | 0.8 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 0.2 | 4.0 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.2 | 7.1 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.2 | 1.0 | GO:0030242 | pexophagy(GO:0030242) |
| 0.2 | 0.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.2 | 5.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.2 | 1.0 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.2 | 1.3 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
| 0.2 | 1.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 | 1.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.2 | 2.6 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.2 | 2.6 | GO:0019695 | choline metabolic process(GO:0019695) |
| 0.2 | 0.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.2 | 0.6 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
| 0.2 | 1.9 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 0.2 | 14.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.2 | 6.0 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.2 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.2 | 7.9 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
| 0.2 | 2.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.2 | 0.9 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.2 | 9.7 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.2 | 0.6 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.2 | 2.6 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.2 | 0.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.2 | 0.7 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.2 | 0.9 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 | 1.3 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.2 | 0.5 | GO:2000855 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
| 0.2 | 0.5 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.2 | 0.9 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.2 | 0.2 | GO:0001743 | optic placode formation(GO:0001743) |
| 0.2 | 0.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.2 | 1.1 | GO:0018032 | protein amidation(GO:0018032) |
| 0.2 | 0.4 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.2 | 0.5 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.2 | 2.9 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
| 0.2 | 1.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
| 0.2 | 0.2 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.2 | 2.7 | GO:0014889 | muscle atrophy(GO:0014889) |
| 0.2 | 1.6 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
| 0.2 | 0.7 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.2 | 1.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.2 | 3.5 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.2 | 0.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.2 | 1.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.2 | 1.9 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.2 | 0.9 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.2 | 1.6 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.2 | 0.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.2 | 0.3 | GO:0099563 | modification of synaptic structure(GO:0099563) |
| 0.2 | 0.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.2 | 0.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.2 | 1.9 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.2 | 12.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.2 | 0.3 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.2 | 0.5 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
| 0.2 | 0.2 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.2 | 10.8 | GO:0006414 | translational elongation(GO:0006414) |
| 0.2 | 1.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.2 | 1.3 | GO:0051450 | myoblast proliferation(GO:0051450) |
| 0.2 | 0.7 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.2 | 0.3 | GO:0048769 | sarcomerogenesis(GO:0048769) |
| 0.2 | 0.5 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.2 | 1.2 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
| 0.2 | 0.7 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.2 | 0.8 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.2 | 0.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.2 | 0.5 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.2 | 0.7 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
| 0.2 | 2.8 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.2 | 0.8 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.2 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.2 | 1.5 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.2 | 3.5 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.2 | 2.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.2 | 0.6 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
| 0.2 | 1.0 | GO:0060437 | lung growth(GO:0060437) |
| 0.2 | 0.6 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.2 | 0.9 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
| 0.2 | 0.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.2 | 2.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.2 | 0.8 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
| 0.2 | 2.2 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
| 0.2 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.2 | 1.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.2 | 0.5 | GO:1904586 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 0.2 | 0.5 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
| 0.2 | 0.6 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.2 | 0.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.2 | 0.3 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.2 | 0.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.2 | 0.5 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
| 0.2 | 1.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.2 | 0.6 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 | 9.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.1 | 1.3 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
| 0.1 | 0.3 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
| 0.1 | 0.7 | GO:0007494 | midgut development(GO:0007494) |
| 0.1 | 2.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 | 1.6 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
| 0.1 | 2.2 | GO:0051231 | spindle elongation(GO:0051231) |
| 0.1 | 3.7 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
| 0.1 | 0.4 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
| 0.1 | 1.0 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
| 0.1 | 6.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 0.1 | 0.4 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
| 0.1 | 0.4 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.1 | 2.7 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.1 | 1.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.1 | 0.1 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
| 0.1 | 0.9 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 | 9.3 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.1 | 0.8 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.1 | 0.4 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
| 0.1 | 3.8 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 2.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.1 | 0.4 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
| 0.1 | 2.2 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 1.5 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.1 | 0.7 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.1 | 0.4 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.1 | 0.3 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.1 | 1.3 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.1 | 1.7 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.1 | 0.5 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.1 | 0.3 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
| 0.1 | 0.8 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 | 3.0 | GO:0006505 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.1 | 0.8 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.1 | 0.3 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.1 | 0.8 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.1 | 0.5 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
| 0.1 | 1.9 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 | 1.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 0.8 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.1 | 0.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 0.1 | 1.0 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.1 | 0.5 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.1 | 9.4 | GO:0019395 | fatty acid oxidation(GO:0019395) |
| 0.1 | 1.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 | 3.0 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 | 0.4 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.1 | 0.2 | GO:0043092 | L-amino acid import(GO:0043092) |
| 0.1 | 0.9 | GO:0060068 | vagina development(GO:0060068) |
| 0.1 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.1 | 0.1 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
| 0.1 | 0.4 | GO:0061568 | dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 0.1 | 0.9 | GO:0016129 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.1 | 0.1 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
| 0.1 | 0.2 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.1 | 1.1 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 | 1.8 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.1 | 0.1 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.1 | 1.4 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.1 | 0.5 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 | 1.5 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
| 0.1 | 0.7 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.1 | 0.6 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.1 | 1.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 0.8 | GO:0072348 | sulfur compound transport(GO:0072348) |
| 0.1 | 0.3 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
| 0.1 | 0.6 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.1 | 0.9 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 | 0.6 | GO:0072567 | chemokine (C-X-C motif) ligand 2 production(GO:0072567) |
| 0.1 | 1.8 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.1 | 1.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.1 | 0.1 | GO:1902232 | regulation of positive thymic T cell selection(GO:1902232) |
| 0.1 | 0.2 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
| 0.1 | 2.6 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.1 | 0.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 | 0.2 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.1 | 0.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.1 | 0.8 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 | 1.8 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
| 0.1 | 14.8 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
| 0.1 | 0.3 | GO:0051788 | response to misfolded protein(GO:0051788) |
| 0.1 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.1 | 0.5 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.1 | 0.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.1 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
| 0.1 | 0.4 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
| 0.1 | 1.4 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
| 0.1 | 0.1 | GO:1901159 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.1 | 0.3 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 | 1.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.1 | 0.1 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.1 | 0.7 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.1 | 0.3 | GO:0009410 | response to xenobiotic stimulus(GO:0009410) |
| 0.1 | 0.7 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
| 0.1 | 1.2 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 0.3 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) DNA demethylation of male pronucleus(GO:0044727) |
| 0.1 | 0.4 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.1 | 0.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 0.1 | 3.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.1 | 1.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 | 2.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 | 0.6 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 | 0.8 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 | 0.5 | GO:0032026 | response to magnesium ion(GO:0032026) |
| 0.1 | 0.5 | GO:0015846 | polyamine transport(GO:0015846) |
| 0.1 | 0.2 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.1 | 5.2 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 | 3.0 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 | 1.1 | GO:0033198 | response to ATP(GO:0033198) |
| 0.1 | 1.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 | 0.9 | GO:0042407 | cristae formation(GO:0042407) |
| 0.1 | 0.1 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.1 | 0.3 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.1 | 0.3 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.1 | 0.2 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.1 | 0.2 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.1 | 0.3 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.1 | 0.1 | GO:0044256 | angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
| 0.1 | 3.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 0.1 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
| 0.1 | 0.3 | GO:0033046 | negative regulation of sister chromatid segregation(GO:0033046) negative regulation of chromosome segregation(GO:0051985) |
| 0.1 | 0.3 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.1 | 0.2 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
| 0.1 | 0.3 | GO:0021997 | neural plate axis specification(GO:0021997) |
| 0.1 | 0.2 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.1 | 0.3 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.1 | 3.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.1 | 0.8 | GO:0021591 | ventricular system development(GO:0021591) |
| 0.1 | 1.4 | GO:0033260 | nuclear DNA replication(GO:0033260) |
| 0.1 | 0.2 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.1 | 0.9 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.1 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
| 0.1 | 0.5 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.1 | 0.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 | 0.2 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.1 | 1.1 | GO:0060079 | excitatory postsynaptic potential(GO:0060079) |
| 0.1 | 0.8 | GO:0042311 | vasodilation(GO:0042311) |
| 0.1 | 0.3 | GO:0021831 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
| 0.1 | 0.5 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.1 | 0.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.1 | 2.9 | GO:0061512 | protein localization to cilium(GO:0061512) |
| 0.1 | 0.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 | 0.3 | GO:0008228 | opsonization(GO:0008228) |
| 0.1 | 0.4 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 0.1 | 0.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 | 0.3 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.1 | 0.2 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.1 | 0.3 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 0.1 | 0.9 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.1 | 1.2 | GO:0050848 | regulation of calcium-mediated signaling(GO:0050848) |
| 0.1 | 0.2 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.1 | 0.9 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
| 0.1 | 0.3 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
| 0.1 | 0.5 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 | 0.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.1 | 0.5 | GO:0043201 | response to leucine(GO:0043201) |
| 0.1 | 0.2 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.1 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
| 0.1 | 0.2 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.1 | 0.2 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.1 | 0.2 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
| 0.1 | 0.2 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.1 | 2.3 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
| 0.1 | 0.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.1 | 0.4 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
| 0.1 | 1.4 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.1 | 2.1 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.1 | 0.4 | GO:0014870 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to stimulus involved in regulation of muscle adaptation(GO:0014874) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 | 0.1 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 0.1 | 0.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 | 1.2 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.1 | 0.4 | GO:1904970 | brush border assembly(GO:1904970) |
| 0.1 | 0.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.1 | 0.3 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.1 | 0.1 | GO:0008272 | sulfate transport(GO:0008272) |
| 0.1 | 0.5 | GO:0030002 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
| 0.1 | 0.1 | GO:0006826 | iron ion transport(GO:0006826) |
| 0.1 | 0.3 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
| 0.1 | 0.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 | 0.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) |
| 0.1 | 0.2 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 | 0.2 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
| 0.1 | 1.5 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.1 | 0.8 | GO:0035994 | response to muscle stretch(GO:0035994) |
| 0.1 | 0.7 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.1 | 0.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.1 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 0.6 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.1 | 0.3 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
| 0.1 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.1 | 0.7 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
| 0.1 | 0.1 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
| 0.1 | 0.1 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
| 0.1 | 0.6 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.1 | 0.1 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.1 | 0.6 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.1 | 0.6 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 | 0.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
| 0.1 | 0.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.1 | 0.1 | GO:1902564 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) negative regulation of neutrophil activation(GO:1902564) regulation of eosinophil activation(GO:1902566) |
| 0.1 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.1 | 0.7 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
| 0.1 | 1.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.1 | 0.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 | 0.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
| 0.1 | 0.6 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.1 | 0.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
| 0.1 | 0.1 | GO:0021871 | forebrain regionalization(GO:0021871) |
| 0.1 | 0.2 | GO:0090671 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) |
| 0.1 | 0.5 | GO:0032328 | alanine transport(GO:0032328) |
| 0.1 | 0.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 | 1.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.1 | 0.8 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.1 | 0.2 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.1 | 0.5 | GO:0001556 | oocyte maturation(GO:0001556) |
| 0.1 | 0.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.1 | 1.0 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.1 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 | 0.4 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 | 0.3 | GO:0048484 | enteric nervous system development(GO:0048484) |
| 0.1 | 0.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
| 0.1 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 | 0.4 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
| 0.1 | 1.0 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.1 | 0.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.1 | 1.2 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.1 | 0.7 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 | 1.4 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
| 0.1 | 0.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.0 | 2.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 | 0.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
| 0.0 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.0 | 0.4 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 | 0.4 | GO:0006284 | base-excision repair(GO:0006284) |
| 0.0 | 0.7 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.0 | 0.7 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.0 | 0.6 | GO:0043486 | histone exchange(GO:0043486) |
| 0.0 | 0.2 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.0 | 0.1 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.0 | 0.1 | GO:0097107 | postsynaptic density assembly(GO:0097107) |
| 0.0 | 0.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.0 | 0.1 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.0 | 0.4 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.0 | 0.2 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
| 0.0 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.0 | 0.1 | GO:1903980 | positive regulation of microglial cell activation(GO:1903980) |
| 0.0 | 0.2 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.0 | 0.2 | GO:0042092 | type 2 immune response(GO:0042092) |
| 0.0 | 0.1 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.0 | 0.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.0 | 0.2 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
| 0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.0 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.0 | 0.3 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.0 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.0 | 1.3 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.0 | 1.1 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 | 0.0 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.0 | 0.2 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
| 0.0 | 0.1 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
| 0.0 | 0.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 | 0.4 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
| 0.0 | 0.1 | GO:0045623 | negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) negative regulation of alpha-beta T cell differentiation(GO:0046639) |
| 0.0 | 0.0 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
| 0.0 | 0.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.0 | 2.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.0 | 0.1 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.0 | 0.2 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.0 | 0.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 | 0.1 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
| 0.0 | 0.1 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.0 | 0.2 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.0 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.0 | 0.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.0 | 0.1 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.0 | 0.2 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.0 | 0.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 | 0.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.0 | 0.4 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.0 | 0.1 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
| 0.0 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.0 | 0.0 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
| 0.0 | 0.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.0 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.0 | 0.1 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
| 0.0 | 0.4 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 | 1.2 | GO:0055072 | iron ion homeostasis(GO:0055072) |
| 0.0 | 0.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
| 0.0 | 0.0 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 | 0.5 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.0 | 0.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.0 | 0.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.0 | 0.0 | GO:0016074 | snoRNA metabolic process(GO:0016074) snoRNA processing(GO:0043144) |
| 0.0 | 0.1 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.0 | 0.0 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.0 | 0.1 | GO:0050993 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.0 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 | 0.1 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
| 0.0 | 0.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.0 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.0 | 0.1 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.0 | 0.4 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.0 | 0.1 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.0 | 0.1 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.0 | 0.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 0.0 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.0 | 0.1 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
| 0.0 | 2.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 | 0.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
| 0.0 | 0.0 | GO:0006563 | L-serine metabolic process(GO:0006563) |
| 0.0 | 0.1 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
| 0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.0 | 0.0 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.0 | 0.0 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
| 0.0 | 0.1 | GO:0050764 | regulation of phagocytosis(GO:0050764) |
| 0.0 | 0.0 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.0 | 0.0 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 | 0.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 | 0.0 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
| 0.0 | 0.0 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.0 | 0.2 | GO:0051782 | negative regulation of cell division(GO:0051782) |
| 0.0 | 0.1 | GO:0038001 | paracrine signaling(GO:0038001) |
| 0.0 | 0.1 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.0 | 0.2 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 | 0.0 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.0 | 0.0 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.0 | 0.5 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.0 | 0.0 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
| 0.0 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
| 0.0 | 0.0 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 0.0 | 0.0 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.0 | 15.0 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 4.3 | 13.0 | GO:0098855 | HCN channel complex(GO:0098855) |
| 3.8 | 38.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 3.0 | 18.2 | GO:0071797 | LUBAC complex(GO:0071797) |
| 2.9 | 14.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 2.6 | 10.2 | GO:0000811 | GINS complex(GO:0000811) |
| 2.5 | 7.5 | GO:0035101 | FACT complex(GO:0035101) |
| 2.3 | 11.7 | GO:0002133 | polycystin complex(GO:0002133) |
| 2.2 | 4.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 2.1 | 10.4 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 2.0 | 6.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 1.9 | 1.9 | GO:0097422 | tubular endosome(GO:0097422) |
| 1.9 | 7.5 | GO:0031523 | Myb complex(GO:0031523) |
| 1.9 | 7.4 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 1.8 | 10.7 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 1.8 | 14.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 1.8 | 10.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 1.7 | 5.2 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 1.7 | 6.7 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 1.7 | 5.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 1.7 | 3.3 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
| 1.7 | 5.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 1.6 | 8.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 1.6 | 1.6 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 1.6 | 9.7 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 1.6 | 6.4 | GO:0044753 | amphisome(GO:0044753) |
| 1.6 | 20.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 1.5 | 11.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 1.5 | 11.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 1.5 | 1.5 | GO:0032783 | ELL-EAF complex(GO:0032783) |
| 1.4 | 8.7 | GO:0071817 | MMXD complex(GO:0071817) |
| 1.4 | 13.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 1.4 | 11.4 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 1.4 | 15.7 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 1.4 | 5.7 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 1.4 | 7.1 | GO:0070701 | mucus layer(GO:0070701) |
| 1.4 | 9.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 1.4 | 4.1 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
| 1.4 | 6.8 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 1.3 | 4.0 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 1.3 | 8.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 1.3 | 18.4 | GO:0070652 | HAUS complex(GO:0070652) |
| 1.3 | 38.9 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 1.2 | 14.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 1.2 | 1.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 1.2 | 16.1 | GO:0000796 | condensin complex(GO:0000796) |
| 1.2 | 8.6 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 1.2 | 18.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 1.2 | 4.7 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
| 1.2 | 4.7 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 1.2 | 4.7 | GO:0097196 | Shu complex(GO:0097196) |
| 1.1 | 9.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 1.1 | 7.8 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 1.1 | 3.3 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 1.1 | 12.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 1.1 | 6.5 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 1.1 | 3.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 1.1 | 15.2 | GO:0042555 | MCM complex(GO:0042555) |
| 1.1 | 6.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 1.1 | 19.2 | GO:0005861 | troponin complex(GO:0005861) |
| 1.1 | 7.5 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 1.1 | 8.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 1.0 | 3.1 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 1.0 | 4.2 | GO:0097361 | CIA complex(GO:0097361) |
| 1.0 | 5.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 1.0 | 14.5 | GO:0033269 | internode region of axon(GO:0033269) |
| 1.0 | 10.4 | GO:0005638 | lamin filament(GO:0005638) |
| 1.0 | 12.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 1.0 | 4.1 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 1.0 | 26.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 1.0 | 5.0 | GO:1990031 | pinceau fiber(GO:1990031) |
| 1.0 | 8.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 1.0 | 1.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 1.0 | 16.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.9 | 5.7 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.9 | 1.9 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.9 | 2.8 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
| 0.9 | 3.7 | GO:1990742 | microvesicle(GO:1990742) |
| 0.9 | 2.8 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
| 0.9 | 5.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.9 | 4.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.9 | 3.6 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
| 0.9 | 1.8 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 0.9 | 2.6 | GO:0034657 | GID complex(GO:0034657) |
| 0.9 | 4.3 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.9 | 12.8 | GO:0005883 | neurofilament(GO:0005883) |
| 0.8 | 3.4 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.8 | 5.1 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.8 | 9.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.8 | 17.8 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.8 | 2.4 | GO:0070685 | macropinocytic cup(GO:0070685) |
| 0.8 | 15.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.8 | 1.5 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.8 | 0.8 | GO:0016342 | catenin complex(GO:0016342) |
| 0.8 | 2.3 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
| 0.8 | 59.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.8 | 2.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.8 | 28.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.8 | 11.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.8 | 2.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.8 | 17.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.7 | 1.5 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.7 | 4.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.7 | 5.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.7 | 14.7 | GO:0032059 | bleb(GO:0032059) |
| 0.7 | 30.6 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.7 | 56.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.7 | 1.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.7 | 1.4 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 0.7 | 2.9 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.7 | 5.0 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.7 | 2.8 | GO:0043293 | apoptosome(GO:0043293) |
| 0.7 | 4.2 | GO:1990393 | 3M complex(GO:1990393) |
| 0.7 | 3.4 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.7 | 7.2 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.7 | 2.0 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.6 | 6.4 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 0.6 | 7.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.6 | 2.9 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.6 | 4.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.6 | 0.6 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 0.6 | 8.8 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.6 | 4.1 | GO:0098536 | deuterosome(GO:0098536) |
| 0.6 | 16.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.6 | 1.1 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.6 | 2.3 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.6 | 5.0 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.6 | 10.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.6 | 2.8 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.6 | 2.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.5 | 1.6 | GO:0070695 | FHF complex(GO:0070695) |
| 0.5 | 3.8 | GO:0032009 | early phagosome(GO:0032009) |
| 0.5 | 2.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.5 | 6.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.5 | 3.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.5 | 1.6 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.5 | 8.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.5 | 3.7 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.5 | 1.6 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.5 | 1.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.5 | 3.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.5 | 1.5 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.5 | 9.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.5 | 3.0 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.5 | 2.0 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.5 | 13.4 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.5 | 7.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.5 | 0.5 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
| 0.5 | 0.5 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
| 0.5 | 6.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.5 | 9.3 | GO:0036038 | MKS complex(GO:0036038) |
| 0.5 | 9.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.5 | 17.5 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.5 | 5.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.5 | 5.2 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.5 | 2.7 | GO:0043196 | varicosity(GO:0043196) |
| 0.5 | 36.2 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.5 | 1.8 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.5 | 5.9 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.4 | 2.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.4 | 1.8 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.4 | 2.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.4 | 4.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.4 | 0.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.4 | 1.7 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 0.4 | 1.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.4 | 7.2 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.4 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.4 | 2.9 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
| 0.4 | 54.8 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.4 | 2.5 | GO:0032021 | NELF complex(GO:0032021) |
| 0.4 | 2.0 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.4 | 1.2 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.4 | 0.8 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.4 | 4.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.4 | 3.2 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.4 | 2.0 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.4 | 0.4 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
| 0.4 | 1.2 | GO:0009346 | citrate lyase complex(GO:0009346) |
| 0.4 | 1.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.4 | 1.9 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 0.4 | 4.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.4 | 5.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.4 | 3.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.4 | 4.9 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.4 | 6.4 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.4 | 3.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.4 | 1.9 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.4 | 1.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.4 | 1.9 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.4 | 2.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.4 | 1.5 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.4 | 6.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.4 | 0.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.4 | 3.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.4 | 11.8 | GO:0000145 | exocyst(GO:0000145) |
| 0.4 | 3.2 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.4 | 1.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.4 | 1.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.4 | 2.8 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.4 | 1.4 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.4 | 1.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 0.3 | 8.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.3 | 1.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.3 | 0.3 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.3 | 6.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.3 | 2.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
| 0.3 | 10.3 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.3 | 2.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
| 0.3 | 3.7 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.3 | 42.2 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.3 | 1.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.3 | 3.3 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.3 | 2.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.3 | 1.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.3 | 11.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.3 | 1.0 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
| 0.3 | 1.6 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.3 | 1.9 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.3 | 5.6 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.3 | 3.7 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) |
| 0.3 | 1.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.3 | 1.5 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.3 | 12.0 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.3 | 0.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.3 | 6.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.3 | 4.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.3 | 3.2 | GO:0034709 | methylosome(GO:0034709) |
| 0.3 | 1.7 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.3 | 8.4 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.3 | 0.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.3 | 6.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.3 | 2.8 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.3 | 0.8 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.3 | 1.4 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.3 | 3.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.3 | 1.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.3 | 0.3 | GO:0044393 | microspike(GO:0044393) |
| 0.3 | 1.0 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.3 | 1.8 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.3 | 4.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.3 | 1.3 | GO:0000938 | GARP complex(GO:0000938) |
| 0.3 | 0.8 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.3 | 1.8 | GO:0042825 | TAP complex(GO:0042825) |
| 0.3 | 3.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.2 | 3.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.2 | 9.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.2 | 1.9 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.2 | 1.9 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.2 | 1.7 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.2 | 1.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.2 | 18.7 | GO:0015935 | small ribosomal subunit(GO:0015935) |
| 0.2 | 2.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.2 | 22.2 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.2 | 0.9 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.2 | 15.2 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.2 | 0.7 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.2 | 4.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.2 | 16.9 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.2 | 3.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.2 | 2.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.2 | 2.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.2 | 12.9 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.2 | 1.1 | GO:0019034 | viral replication complex(GO:0019034) |
| 0.2 | 2.2 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.2 | 0.2 | GO:0031256 | leading edge membrane(GO:0031256) |
| 0.2 | 7.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.2 | 4.1 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
| 0.2 | 1.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.2 | 15.9 | GO:0016235 | aggresome(GO:0016235) |
| 0.2 | 5.3 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.2 | 0.9 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.2 | 5.6 | GO:0044853 | plasma membrane raft(GO:0044853) |
| 0.2 | 2.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.2 | 5.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.2 | 5.5 | GO:0031513 | nonmotile primary cilium(GO:0031513) primary cilium(GO:0072372) |
| 0.2 | 1.2 | GO:0070938 | contractile ring(GO:0070938) |
| 0.2 | 1.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.2 | 2.0 | GO:0060091 | kinocilium(GO:0060091) |
| 0.2 | 0.8 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.2 | 0.8 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.2 | 7.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.2 | 13.0 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.2 | 2.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.2 | 12.8 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
| 0.2 | 1.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.2 | 1.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.2 | 0.8 | GO:0001740 | Barr body(GO:0001740) |
| 0.2 | 4.8 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.2 | 1.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.2 | 1.5 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 0.2 | 8.9 | GO:0005657 | replication fork(GO:0005657) |
| 0.2 | 5.9 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.2 | 2.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.2 | 3.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.2 | 0.3 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.2 | 0.5 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.2 | 2.9 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.2 | 0.9 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.2 | 1.0 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.2 | 20.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.2 | 5.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.2 | 1.7 | GO:0034464 | BBSome(GO:0034464) |
| 0.2 | 0.7 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.2 | 6.5 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 0.2 | 22.2 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
| 0.2 | 0.8 | GO:0000243 | commitment complex(GO:0000243) |
| 0.2 | 10.8 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.2 | 5.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.2 | 2.6 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
| 0.2 | 0.6 | GO:0005712 | chiasma(GO:0005712) |
| 0.2 | 0.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.2 | 11.8 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
| 0.2 | 4.0 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.2 | 2.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.2 | 75.5 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 7.2 | GO:0030673 | axolemma(GO:0030673) |
| 0.1 | 0.3 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.1 | 11.3 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.1 | 2.9 | GO:0000791 | euchromatin(GO:0000791) |
| 0.1 | 6.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 0.7 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.1 | 3.0 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.1 | 0.7 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.1 | 1.2 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.1 | 0.5 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 0.1 | 0.5 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.1 | 0.1 | GO:0071010 | prespliceosome(GO:0071010) |
| 0.1 | 11.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 1.3 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.1 | 14.4 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
| 0.1 | 2.2 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.1 | 2.9 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.1 | 1.0 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.1 | 1.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.1 | 0.7 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.1 | 2.0 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.1 | 2.6 | GO:0070382 | exocytic vesicle(GO:0070382) |
| 0.1 | 13.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 4.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.1 | 1.9 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 5.4 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 0.3 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.1 | 1.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.1 | 0.8 | GO:0030891 | VCB complex(GO:0030891) |
| 0.1 | 62.8 | GO:0005740 | mitochondrial envelope(GO:0005740) |
| 0.1 | 3.6 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.1 | 0.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.1 | 9.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 6.3 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.1 | 0.4 | GO:1990357 | terminal web(GO:1990357) |
| 0.1 | 3.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 0.3 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
| 0.1 | 0.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.1 | 3.6 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.1 | 2.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.1 | 0.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.1 | 0.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.1 | 1.8 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.1 | 0.9 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.1 | 0.4 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.1 | 8.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.1 | 6.0 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.1 | 0.4 | GO:0019866 | organelle inner membrane(GO:0019866) |
| 0.1 | 0.6 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.1 | 0.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.1 | 3.6 | GO:0031672 | A band(GO:0031672) |
| 0.1 | 0.6 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.1 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.1 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.1 | 0.1 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.1 | 0.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.1 | 2.9 | GO:0032421 | stereocilium bundle(GO:0032421) |
| 0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 2.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 0.4 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
| 0.1 | 0.3 | GO:0008091 | spectrin(GO:0008091) |
| 0.1 | 2.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.1 | 0.2 | GO:0031251 | PAN complex(GO:0031251) |
| 0.1 | 4.4 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.1 | 4.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.1 | 0.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.1 | 1.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
| 0.0 | 0.9 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.0 | 1.1 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.0 | 0.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 0.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.0 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.0 | 0.4 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
| 0.0 | 5.1 | GO:0005874 | microtubule(GO:0005874) |
| 0.0 | 0.9 | GO:0030904 | retromer complex(GO:0030904) |
| 0.0 | 0.4 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.0 | 0.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.0 | 0.3 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
| 0.0 | 0.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.0 | 0.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.0 | 0.1 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.0 | 0.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.0 | 0.1 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.0 | 2.1 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.0 | 0.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 0.1 | GO:0060187 | cell pole(GO:0060187) |
| 0.0 | 0.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.0 | 0.1 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 0.0 | 0.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.0 | 1.1 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.0 | 152.9 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.0 | 1.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.0 | 0.1 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
| 0.0 | 0.1 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 0.0 | 0.0 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.0 | 0.0 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.0 | 0.1 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.0 | 0.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.0 | 6.0 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
| 6.0 | 18.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 5.9 | 29.3 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 5.5 | 27.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 3.9 | 11.8 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
| 3.5 | 14.0 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 3.5 | 20.9 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 3.5 | 3.5 | GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen(GO:0016705) |
| 3.4 | 13.5 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 3.2 | 6.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 3.1 | 12.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 3.0 | 9.1 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 2.9 | 8.8 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 2.9 | 14.7 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 2.9 | 5.8 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 2.9 | 8.6 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 2.8 | 8.5 | GO:0015039 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 2.8 | 8.3 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 2.7 | 8.2 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
| 2.7 | 16.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 2.6 | 21.0 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 2.6 | 10.4 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 2.6 | 7.8 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 2.6 | 15.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 2.6 | 15.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 2.5 | 12.7 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 2.5 | 2.5 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
| 2.5 | 17.4 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 2.5 | 12.4 | GO:0004672 | protein kinase activity(GO:0004672) |
| 2.4 | 12.1 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 2.3 | 11.7 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 2.3 | 7.0 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 2.3 | 6.9 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 2.3 | 9.1 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 2.3 | 2.3 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 2.2 | 6.7 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
| 2.2 | 8.8 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 2.2 | 6.6 | GO:0015131 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
| 2.2 | 13.0 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 2.1 | 6.3 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
| 2.1 | 12.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 2.1 | 6.3 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 2.0 | 4.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
| 2.0 | 28.4 | GO:0031014 | troponin T binding(GO:0031014) |
| 2.0 | 2.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 2.0 | 17.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 2.0 | 5.9 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
| 2.0 | 15.7 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
| 1.9 | 1.9 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 1.9 | 9.6 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 1.9 | 3.9 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 1.9 | 5.7 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 1.9 | 5.7 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
| 1.9 | 16.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 1.9 | 5.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 1.9 | 7.5 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 1.9 | 7.4 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 1.8 | 16.5 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 1.8 | 7.3 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 1.8 | 12.7 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 1.8 | 5.3 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 1.7 | 22.7 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 1.7 | 5.2 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 1.7 | 6.9 | GO:0004335 | galactokinase activity(GO:0004335) |
| 1.7 | 13.7 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 1.7 | 6.9 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 1.7 | 6.8 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 1.7 | 20.4 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 1.7 | 5.0 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 1.7 | 5.0 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
| 1.6 | 4.9 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 1.6 | 16.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 1.6 | 8.2 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 1.6 | 9.8 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
| 1.6 | 1.6 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 1.6 | 4.8 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
| 1.6 | 4.7 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 1.6 | 4.7 | GO:0031403 | pyridoxal kinase activity(GO:0008478) lithium ion binding(GO:0031403) |
| 1.6 | 4.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 1.5 | 18.6 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 1.5 | 1.5 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 1.5 | 7.7 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 1.5 | 4.6 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
| 1.5 | 7.6 | GO:0097016 | L27 domain binding(GO:0097016) |
| 1.5 | 10.5 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
| 1.5 | 10.4 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 1.5 | 8.8 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 1.4 | 4.3 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 1.4 | 4.3 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 1.4 | 13.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 1.4 | 2.9 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 1.4 | 8.6 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 1.4 | 4.3 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 1.4 | 4.3 | GO:0047291 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
| 1.4 | 7.1 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 1.4 | 4.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 1.4 | 4.3 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
| 1.4 | 7.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 1.4 | 5.6 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
| 1.4 | 5.6 | GO:0098809 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
| 1.4 | 4.2 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
| 1.4 | 4.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 1.4 | 4.1 | GO:0016898 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
| 1.4 | 4.1 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
| 1.4 | 6.8 | GO:0005287 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
| 1.3 | 12.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 1.3 | 4.0 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 1.3 | 3.9 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 1.3 | 3.9 | GO:0016855 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 1.3 | 3.9 | GO:0052831 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 1.3 | 11.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 1.3 | 2.5 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 1.3 | 2.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 1.3 | 3.8 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
| 1.3 | 3.8 | GO:0051908 | double-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0051908) |
| 1.3 | 5.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 1.3 | 3.8 | GO:0016250 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
| 1.2 | 6.2 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 1.2 | 3.7 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 1.2 | 3.7 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 1.2 | 3.6 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 1.2 | 4.8 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 1.2 | 8.3 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 1.2 | 5.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 1.2 | 3.5 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
| 1.2 | 3.5 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 1.2 | 11.7 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 1.2 | 7.0 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 1.2 | 1.2 | GO:0016653 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
| 1.2 | 3.5 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 1.1 | 2.3 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 1.1 | 3.4 | GO:0045142 | triplex DNA binding(GO:0045142) |
| 1.1 | 7.9 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 1.1 | 11.3 | GO:0048156 | tau protein binding(GO:0048156) |
| 1.1 | 3.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 1.1 | 3.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 1.1 | 3.4 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 1.1 | 15.7 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 1.1 | 3.4 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 1.1 | 15.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 1.1 | 5.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 1.1 | 4.4 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 1.1 | 5.5 | GO:0070905 | serine binding(GO:0070905) |
| 1.1 | 5.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 1.1 | 5.5 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 1.1 | 4.4 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 1.1 | 3.3 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 1.1 | 3.3 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 1.1 | 4.3 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 1.1 | 15.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 1.1 | 1.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 1.1 | 3.2 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 1.1 | 3.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 1.1 | 7.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 1.0 | 9.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 1.0 | 3.1 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
| 1.0 | 3.1 | GO:0003774 | motor activity(GO:0003774) |
| 1.0 | 11.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 1.0 | 12.4 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 1.0 | 12.4 | GO:0039706 | co-receptor binding(GO:0039706) |
| 1.0 | 8.3 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 1.0 | 21.6 | GO:0003680 | AT DNA binding(GO:0003680) |
| 1.0 | 5.1 | GO:0031996 | thioesterase binding(GO:0031996) |
| 1.0 | 8.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 1.0 | 3.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 1.0 | 6.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 1.0 | 7.0 | GO:0005497 | androgen binding(GO:0005497) |
| 1.0 | 8.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 1.0 | 2.0 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
| 1.0 | 6.9 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 1.0 | 1.0 | GO:0070402 | NADPH binding(GO:0070402) |
| 1.0 | 6.8 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 1.0 | 1.9 | GO:0002060 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
| 1.0 | 4.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 1.0 | 3.9 | GO:0005019 | platelet-derived growth factor beta-receptor activity(GO:0005019) |
| 1.0 | 2.9 | GO:0097259 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 1.0 | 18.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 1.0 | 11.5 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 1.0 | 12.4 | GO:0015232 | heme transporter activity(GO:0015232) |
| 1.0 | 3.8 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 1.0 | 6.7 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.9 | 6.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.9 | 2.8 | GO:0048244 | phytanoyl-CoA dioxygenase activity(GO:0048244) |
| 0.9 | 10.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.9 | 5.5 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.9 | 1.8 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
| 0.9 | 6.4 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
| 0.9 | 2.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.9 | 2.7 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.9 | 7.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.9 | 3.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.9 | 2.7 | GO:0033961 | cis-stilbene-oxide hydrolase activity(GO:0033961) |
| 0.9 | 3.6 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.9 | 2.7 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 0.9 | 4.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.9 | 7.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 0.9 | 0.9 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.9 | 8.8 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.9 | 19.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.9 | 3.5 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 0.9 | 1.7 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.9 | 3.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.9 | 3.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.9 | 2.6 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.8 | 0.8 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
| 0.8 | 7.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.8 | 2.5 | GO:0015067 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
| 0.8 | 2.5 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.8 | 2.5 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.8 | 0.8 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
| 0.8 | 44.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.8 | 3.3 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.8 | 3.3 | GO:0004803 | transposase activity(GO:0004803) |
| 0.8 | 2.5 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.8 | 7.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.8 | 2.5 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.8 | 5.0 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.8 | 4.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.8 | 2.5 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
| 0.8 | 4.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.8 | 7.4 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
| 0.8 | 9.0 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.8 | 3.2 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.8 | 5.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.8 | 3.2 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.8 | 4.0 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
| 0.8 | 0.8 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 0.8 | 9.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.8 | 3.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.8 | 6.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.8 | 5.5 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.8 | 9.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.8 | 7.7 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.8 | 5.4 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.8 | 7.7 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.8 | 3.1 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.8 | 3.8 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.8 | 4.6 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.8 | 3.8 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
| 0.8 | 6.8 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.8 | 0.8 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
| 0.7 | 10.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.7 | 6.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.7 | 3.7 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.7 | 2.2 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
| 0.7 | 3.0 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 0.7 | 2.9 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.7 | 7.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.7 | 3.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.7 | 4.3 | GO:0016531 | copper chaperone activity(GO:0016531) |
| 0.7 | 5.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.7 | 2.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.7 | 0.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.7 | 10.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 0.7 | 9.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.7 | 2.8 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.7 | 8.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.7 | 12.7 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.7 | 5.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.7 | 2.1 | GO:0004103 | choline kinase activity(GO:0004103) |
| 0.7 | 2.8 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
| 0.7 | 21.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.7 | 3.5 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.7 | 8.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.7 | 2.8 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.7 | 23.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.7 | 1.4 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.7 | 2.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
| 0.7 | 6.1 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.7 | 2.7 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
| 0.7 | 2.7 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.7 | 3.4 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 0.7 | 2.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.7 | 3.4 | GO:0035276 | ethanol binding(GO:0035276) |
| 0.7 | 2.7 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.7 | 2.7 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.7 | 10.0 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.7 | 2.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.7 | 8.6 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.7 | 5.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.7 | 6.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.7 | 7.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.7 | 2.0 | GO:0008124 | phenylalanine 4-monooxygenase activity(GO:0004505) 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
| 0.7 | 6.6 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.7 | 2.6 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
| 0.6 | 1.9 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.6 | 1.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
| 0.6 | 2.6 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.6 | 12.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.6 | 1.9 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.6 | 3.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.6 | 1.9 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
| 0.6 | 9.5 | GO:0003909 | DNA ligase activity(GO:0003909) |
| 0.6 | 3.8 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.6 | 1.9 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 0.6 | 1.9 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.6 | 3.1 | GO:0002046 | opsin binding(GO:0002046) |
| 0.6 | 2.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.6 | 0.6 | GO:0016803 | ether hydrolase activity(GO:0016803) |
| 0.6 | 0.6 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
| 0.6 | 3.1 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.6 | 1.8 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.6 | 1.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.6 | 1.8 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
| 0.6 | 1.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.6 | 1.2 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.6 | 21.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.6 | 1.8 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.6 | 1.8 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.6 | 2.4 | GO:0004057 | arginyltransferase activity(GO:0004057) |
| 0.6 | 5.3 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.6 | 2.4 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.6 | 4.1 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.6 | 5.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.6 | 1.8 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.6 | 0.6 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.6 | 3.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.6 | 11.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.6 | 0.6 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 0.6 | 7.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.6 | 9.8 | GO:0016594 | glycine binding(GO:0016594) |
| 0.6 | 1.7 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.6 | 2.3 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
| 0.6 | 5.7 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.6 | 12.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.6 | 10.7 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.6 | 1.7 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
| 0.6 | 1.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 0.6 | 12.8 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.6 | 2.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.6 | 5.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.6 | 1.1 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 0.6 | 5.5 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
| 0.6 | 1.7 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 0.6 | 2.8 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.5 | 6.0 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.5 | 0.5 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.5 | 7.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.5 | 1.6 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
| 0.5 | 2.2 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.5 | 18.9 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.5 | 0.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.5 | 0.5 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.5 | 4.8 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.5 | 2.1 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
| 0.5 | 4.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.5 | 1.6 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.5 | 14.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.5 | 1.6 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.5 | 4.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.5 | 2.6 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.5 | 3.1 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.5 | 9.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.5 | 4.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.5 | 1.5 | GO:0097689 | iron channel activity(GO:0097689) |
| 0.5 | 2.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.5 | 2.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
| 0.5 | 3.5 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 0.5 | 1.5 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.5 | 2.0 | GO:0009384 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
| 0.5 | 9.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.5 | 3.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.5 | 4.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.5 | 3.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.5 | 2.4 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.5 | 11.6 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.5 | 1.0 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.5 | 2.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.5 | 1.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
| 0.5 | 1.9 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 0.5 | 1.9 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.5 | 2.9 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 0.5 | 10.9 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 0.5 | 8.5 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.5 | 4.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.5 | 18.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.5 | 7.9 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.5 | 2.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.5 | 2.8 | GO:0051870 | methotrexate binding(GO:0051870) |
| 0.5 | 5.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.5 | 1.4 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 0.5 | 14.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.5 | 3.7 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.5 | 3.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.5 | 3.7 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 0.5 | 1.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.5 | 3.2 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.5 | 4.6 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.5 | 3.2 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.5 | 3.6 | GO:0030614 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
| 0.4 | 2.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.4 | 3.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.4 | 1.8 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.4 | 7.2 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.4 | 0.9 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.4 | 7.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.4 | 0.9 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
| 0.4 | 1.8 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.4 | 2.2 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.4 | 17.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.4 | 0.4 | GO:0052827 | inositol pentakisphosphate phosphatase activity(GO:0052827) |
| 0.4 | 2.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.4 | 8.2 | GO:0019207 | kinase regulator activity(GO:0019207) |
| 0.4 | 0.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.4 | 9.5 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.4 | 9.5 | GO:0005522 | profilin binding(GO:0005522) |
| 0.4 | 5.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.4 | 3.0 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.4 | 0.4 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
| 0.4 | 4.2 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.4 | 12.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.4 | 1.3 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.4 | 4.6 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.4 | 4.6 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.4 | 1.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.4 | 2.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.4 | 2.1 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.4 | 1.7 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
| 0.4 | 5.4 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.4 | 1.7 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.4 | 5.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.4 | 3.7 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.4 | 2.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.4 | 2.8 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.4 | 12.9 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.4 | 1.6 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.4 | 0.8 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 0.4 | 19.1 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
| 0.4 | 0.8 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
| 0.4 | 2.0 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
| 0.4 | 2.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.4 | 1.6 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.4 | 1.6 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
| 0.4 | 0.4 | GO:1901338 | dopamine binding(GO:0035240) catecholamine binding(GO:1901338) |
| 0.4 | 2.0 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.4 | 1.2 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 0.4 | 1.2 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.4 | 1.2 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.4 | 1.2 | GO:0070260 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
| 0.4 | 1.2 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.4 | 4.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.4 | 1.6 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.4 | 0.4 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 0.4 | 4.6 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.4 | 3.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.4 | 5.4 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.4 | 24.5 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.4 | 4.6 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
| 0.4 | 0.4 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 0.4 | 1.1 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.4 | 3.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.4 | 4.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.4 | 1.1 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
| 0.4 | 3.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.4 | 6.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.4 | 13.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.4 | 9.8 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.4 | 1.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 0.4 | 2.1 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.4 | 3.9 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.4 | 1.4 | GO:0070404 | NADH binding(GO:0070404) |
| 0.3 | 10.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.3 | 1.0 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.3 | 3.1 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.3 | 3.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.3 | 2.1 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.3 | 1.7 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.3 | 3.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.3 | 1.0 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.3 | 0.7 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 0.3 | 12.0 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.3 | 4.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.3 | 8.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.3 | 2.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.3 | 0.3 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.3 | 1.7 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.3 | 1.0 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.3 | 1.0 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.3 | 3.7 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.3 | 8.7 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 0.3 | 1.0 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
| 0.3 | 10.4 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.3 | 3.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.3 | 14.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.3 | 6.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.3 | 3.3 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.3 | 0.3 | GO:0001159 | core promoter proximal region DNA binding(GO:0001159) |
| 0.3 | 1.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.3 | 1.6 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
| 0.3 | 13.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.3 | 1.6 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.3 | 2.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.3 | 1.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.3 | 4.8 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.3 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.3 | 5.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.3 | 3.5 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.3 | 3.5 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.3 | 0.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.3 | 0.6 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.3 | 0.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.3 | 1.2 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.3 | 1.2 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.3 | 2.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.3 | 0.9 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 0.3 | 2.5 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.3 | 2.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.3 | 3.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
| 0.3 | 1.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.3 | 0.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.3 | 2.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.3 | 1.5 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.3 | 2.1 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.3 | 1.2 | GO:0015375 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
| 0.3 | 2.6 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.3 | 0.6 | GO:0042165 | neurotransmitter binding(GO:0042165) |
| 0.3 | 2.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.3 | 2.9 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.3 | 1.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.3 | 1.7 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.3 | 6.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.3 | 0.3 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.3 | 2.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.3 | 0.6 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.3 | 3.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.3 | 6.0 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.3 | 0.8 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.3 | 2.8 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.3 | 1.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.3 | 1.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.3 | 1.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.3 | 1.1 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
| 0.3 | 1.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.3 | 4.4 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.3 | 0.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.3 | 2.8 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.3 | 1.4 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.3 | 3.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.3 | 2.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.3 | 20.3 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.3 | 3.2 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.3 | 0.5 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.3 | 5.3 | GO:0008061 | chitin binding(GO:0008061) |
| 0.3 | 6.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.3 | 0.3 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.3 | 0.8 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
| 0.3 | 1.3 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.3 | 1.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.3 | 0.8 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.3 | 3.9 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.3 | 1.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.3 | 1.0 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.3 | 2.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.3 | 1.8 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
| 0.3 | 1.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
| 0.3 | 3.1 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
| 0.3 | 2.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.3 | 1.5 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.2 | 0.7 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 0.2 | 1.5 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.2 | 1.5 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.2 | 1.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.2 | 3.0 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.2 | 2.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.2 | 1.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.2 | 7.6 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
| 0.2 | 59.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.2 | 2.7 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.2 | 0.7 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.2 | 11.6 | GO:0005230 | extracellular ligand-gated ion channel activity(GO:0005230) |
| 0.2 | 0.5 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.2 | 0.7 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
| 0.2 | 3.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.2 | 4.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.2 | 0.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.2 | 0.7 | GO:0031783 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
| 0.2 | 2.5 | GO:0035877 | death effector domain binding(GO:0035877) |
| 0.2 | 0.7 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.2 | 0.9 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.2 | 1.8 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.2 | 0.9 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
| 0.2 | 1.6 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.2 | 0.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.2 | 0.7 | GO:0004108 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
| 0.2 | 5.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.2 | 1.1 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.2 | 1.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.2 | 0.7 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
| 0.2 | 0.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.2 | 0.4 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.2 | 1.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.2 | 0.7 | GO:0019862 | IgA binding(GO:0019862) |
| 0.2 | 1.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.2 | 8.1 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.2 | 0.7 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
| 0.2 | 17.2 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.2 | 0.6 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.2 | 1.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.2 | 0.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.2 | 3.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.2 | 0.6 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
| 0.2 | 0.6 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
| 0.2 | 0.8 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.2 | 2.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.2 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
| 0.2 | 1.9 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.2 | 1.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.2 | 2.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.2 | 5.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.2 | 0.6 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 0.2 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.2 | 36.8 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.2 | 2.7 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
| 0.2 | 3.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.2 | 1.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.2 | 0.2 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.2 | 0.2 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.2 | 1.0 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.2 | 4.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.2 | 0.8 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.2 | 5.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.2 | 5.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.2 | 2.7 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.2 | 5.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.2 | 0.8 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
| 0.2 | 1.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.2 | 0.6 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
| 0.2 | 2.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.2 | 1.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.2 | 1.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.2 | 5.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.2 | 8.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.2 | 3.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.2 | 2.9 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.2 | 0.9 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.2 | 0.5 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 0.2 | 0.9 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.2 | 0.4 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.2 | 1.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.2 | 2.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.2 | 0.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.2 | 1.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.2 | 3.3 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.2 | 0.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.2 | 1.9 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.2 | 0.9 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.2 | 1.7 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.2 | 15.8 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.2 | 1.0 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.2 | 0.3 | GO:1990446 | snRNP binding(GO:0070990) U1 snRNP binding(GO:1990446) |
| 0.2 | 1.0 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.2 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.2 | 0.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.2 | 1.5 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.2 | 0.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.2 | 2.5 | GO:0031432 | titin binding(GO:0031432) |
| 0.2 | 2.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.2 | 1.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.2 | 2.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.2 | 0.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.2 | 1.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.2 | 0.6 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.2 | 0.8 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
| 0.2 | 5.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.2 | 0.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
| 0.2 | 0.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.2 | 0.9 | GO:0016301 | kinase activity(GO:0016301) |
| 0.2 | 1.3 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
| 0.2 | 0.9 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.2 | 2.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.2 | 1.1 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.2 | 1.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.2 | 1.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.2 | 0.5 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.2 | 0.8 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
| 0.2 | 0.5 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 0.2 | 3.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.2 | 1.2 | GO:0071253 | connexin binding(GO:0071253) |
| 0.2 | 0.8 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.2 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
| 0.2 | 5.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.2 | 0.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 0.6 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.1 | 6.1 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.1 | 5.9 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.1 | 0.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.1 | 0.1 | GO:0015926 | glucosidase activity(GO:0015926) |
| 0.1 | 1.9 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.1 | 4.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 2.6 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.1 | 1.3 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.1 | 0.9 | GO:0046332 | SMAD binding(GO:0046332) |
| 0.1 | 0.4 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.1 | 0.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.1 | 1.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 1.0 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.1 | 2.0 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.1 | 0.7 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.1 | 0.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.1 | 0.7 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.1 | 0.3 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
| 0.1 | 1.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.1 | 0.7 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
| 0.1 | 1.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.1 | 0.5 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.1 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.1 | 1.2 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.1 | 3.0 | GO:0099600 | transmembrane receptor activity(GO:0099600) |
| 0.1 | 1.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.1 | 1.3 | GO:0016829 | lyase activity(GO:0016829) |
| 0.1 | 0.6 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.1 | 1.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.1 | 0.4 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
| 0.1 | 1.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
| 0.1 | 3.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.1 | 0.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.1 | 4.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.1 | 0.6 | GO:0071949 | FAD binding(GO:0071949) |
| 0.1 | 0.6 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.1 | 4.9 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
| 0.1 | 2.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.1 | 5.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 2.6 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.1 | 2.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 0.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.1 | 3.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 1.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.1 | 0.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.1 | 0.9 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.1 | 0.6 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.1 | 0.1 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
| 0.1 | 1.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.1 | 0.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.1 | 7.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.1 | 0.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
| 0.1 | 3.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 0.4 | GO:0004521 | endoribonuclease activity(GO:0004521) |
| 0.1 | 0.6 | GO:0016874 | ligase activity(GO:0016874) |
| 0.1 | 2.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.1 | 0.5 | GO:0030619 | U1 snRNA binding(GO:0030619) |
| 0.1 | 0.5 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.1 | 1.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.1 | 0.2 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.1 | 0.3 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.1 | 2.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.1 | 3.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
| 0.1 | 0.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.1 | 2.0 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.1 | 2.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.1 | 1.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.1 | 0.6 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
| 0.1 | 0.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
| 0.1 | 0.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.1 | 0.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.1 | 0.5 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.1 | 0.3 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.1 | 0.6 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.1 | 0.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.1 | 0.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.1 | 3.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 0.2 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
| 0.1 | 0.3 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
| 0.1 | 3.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 4.8 | GO:0043621 | protein self-association(GO:0043621) |
| 0.1 | 1.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.1 | 0.3 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
| 0.1 | 0.6 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.1 | 0.3 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.1 | 0.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
| 0.1 | 0.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.1 | 0.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.1 | 0.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.1 | 0.6 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.1 | 0.1 | GO:0005272 | sodium channel activity(GO:0005272) |
| 0.1 | 0.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 3.2 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.1 | 1.9 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.1 | 0.5 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.1 | 0.2 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.1 | 1.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.1 | 0.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.1 | 0.2 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.1 | 0.2 | GO:0004423 | iduronate-2-sulfatase activity(GO:0004423) |
| 0.1 | 2.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 2.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.1 | 0.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.1 | 0.8 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.1 | 1.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.1 | 0.2 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 0.1 | 0.4 | GO:0008047 | enzyme activator activity(GO:0008047) |
| 0.1 | 0.3 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 0.1 | 0.5 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.1 | 0.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.1 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.1 | 0.3 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 0.1 | 0.3 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.1 | 8.8 | GO:0003823 | antigen binding(GO:0003823) |
| 0.1 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 0.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.1 | 0.2 | GO:0042007 | interleukin-18 binding(GO:0042007) |
| 0.1 | 0.3 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
| 0.1 | 0.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.1 | 0.2 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.1 | 0.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.1 | 3.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.1 | 1.6 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.1 | 0.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.1 | 1.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 3.8 | GO:0004527 | exonuclease activity(GO:0004527) |
| 0.1 | 0.1 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.1 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 0.1 | 0.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.1 | 0.2 | GO:0031768 | growth hormone-releasing hormone activity(GO:0016608) ghrelin receptor binding(GO:0031768) |
| 0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.1 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.1 | 0.2 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 0.1 | 0.6 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.1 | 0.2 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.0 | 0.3 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.0 | 1.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.0 | 0.3 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.0 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.0 | 0.7 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.0 | 0.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.0 | 0.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.0 | 0.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.2 | GO:0016917 | GABA receptor activity(GO:0016917) |
| 0.0 | 0.0 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
| 0.0 | 0.0 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
| 0.0 | 0.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.0 | 0.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.0 | 0.0 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
| 0.0 | 1.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.0 | 0.8 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.0 | 1.4 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
| 0.0 | 0.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.0 | 0.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.0 | 0.1 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.0 | 0.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.0 | 0.1 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.0 | 1.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 1.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.0 | 1.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 1.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.0 | 0.1 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
| 0.0 | 0.1 | GO:0016499 | orexin receptor activity(GO:0016499) |
| 0.0 | 0.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.0 | 0.1 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 0.0 | 0.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.0 | 0.1 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.0 | 0.0 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
| 0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.0 | 0.1 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
| 0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.0 | 0.1 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
| 0.0 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
| 0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.0 | 0.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.0 | 1.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.0 | 0.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.0 | 0.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
| 0.0 | 0.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.0 | 0.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.0 | 0.0 | GO:0090556 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 0.0 | 0.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.0 | 2.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.0 | 0.0 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.0 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.0 | 0.2 | GO:0070888 | E-box binding(GO:0070888) |
| 0.0 | 0.2 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.0 | 0.8 | GO:0030295 | protein kinase activator activity(GO:0030295) |
| 0.0 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.0 | 0.0 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 6.1 | PID IGF1 PATHWAY | IGF1 pathway |
| 1.0 | 15.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 1.0 | 5.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.9 | 1.9 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.7 | 2.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.6 | 47.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.6 | 15.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.6 | 50.4 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.6 | 6.3 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.6 | 17.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.5 | 46.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.5 | 10.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.5 | 3.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.5 | 32.3 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.4 | 7.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.4 | 2.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.4 | 24.8 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.4 | 1.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.4 | 4.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.3 | 3.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.3 | 17.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.3 | 14.0 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.3 | 4.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.3 | 6.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.3 | 3.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.2 | 3.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.2 | 5.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.2 | 9.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.2 | 1.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.2 | 2.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.2 | 1.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.2 | 7.6 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.2 | 5.8 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.2 | 11.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.2 | 5.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.2 | 8.7 | PID ATR PATHWAY | ATR signaling pathway |
| 0.2 | 0.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.2 | 5.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.2 | 2.9 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.2 | 2.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.2 | 2.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.2 | 10.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.2 | 1.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.2 | 9.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.1 | 1.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.1 | 6.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 1.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.1 | 22.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.1 | 5.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 0.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 6.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 0.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.1 | 6.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.1 | 4.7 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 5.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.1 | 6.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 2.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 3.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 13.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.1 | 4.9 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.1 | 2.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 6.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.1 | 3.3 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.1 | 4.8 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.1 | 1.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.1 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.1 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.1 | 2.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.1 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 1.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.1 | 7.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 4.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.1 | 1.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.1 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 0.5 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.1 | 3.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 3.9 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 1.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 2.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.1 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 2.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.1 | 2.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 2.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 1.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.0 | 1.6 | PID ATM PATHWAY | ATM pathway |
| 0.0 | 1.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.0 | 4.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 1.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 1.0 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 0.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 2.0 | PID BMP PATHWAY | BMP receptor signaling |
| 0.0 | 0.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.0 | 0.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.0 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.0 | 1.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.0 | 0.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.4 | 9.6 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 2.3 | 2.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 1.8 | 5.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 1.5 | 6.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 1.5 | 29.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 1.5 | 24.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 1.3 | 20.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 1.3 | 31.1 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
| 1.3 | 37.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 1.3 | 21.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 1.2 | 17.9 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 1.2 | 11.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 1.2 | 9.4 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 1.2 | 1.2 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 1.1 | 5.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 1.0 | 9.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.9 | 16.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.9 | 59.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.9 | 22.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.9 | 20.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.9 | 7.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.9 | 1.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.9 | 7.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.8 | 11.9 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.8 | 33.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.8 | 17.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.8 | 14.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.7 | 22.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.7 | 24.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.7 | 4.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.7 | 13.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.7 | 8.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.7 | 24.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.7 | 4.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.7 | 2.0 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.7 | 2.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.6 | 23.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.6 | 1.3 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
| 0.6 | 11.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.6 | 46.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.6 | 18.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.6 | 21.5 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
| 0.6 | 7.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.6 | 12.8 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.6 | 13.7 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.6 | 15.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.6 | 14.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.6 | 10.5 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.5 | 15.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.5 | 40.4 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.5 | 35.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.5 | 19.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.5 | 23.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.5 | 15.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.5 | 4.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.5 | 19.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.5 | 34.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.5 | 5.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.4 | 5.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.4 | 7.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.4 | 30.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.4 | 4.3 | REACTOME NEUROTRANSMITTER RECEPTOR BINDING AND DOWNSTREAM TRANSMISSION IN THE POSTSYNAPTIC CELL | Genes involved in Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell |
| 0.4 | 37.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.4 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.4 | 11.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.4 | 4.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.4 | 4.8 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.4 | 8.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.4 | 1.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.4 | 25.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.4 | 9.8 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.4 | 8.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.3 | 13.4 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
| 0.3 | 17.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.3 | 10.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.3 | 18.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.3 | 12.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.3 | 19.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.3 | 11.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.3 | 8.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.3 | 15.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.3 | 12.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.3 | 0.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 0.3 | 11.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.3 | 16.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.3 | 2.7 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
| 0.3 | 11.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.3 | 4.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.3 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.3 | 5.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.3 | 12.9 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.3 | 3.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.3 | 18.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.3 | 20.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.3 | 15.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.2 | 6.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.2 | 7.4 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.2 | 4.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.2 | 3.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.2 | 12.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.2 | 1.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.2 | 3.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.2 | 5.5 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.2 | 15.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.2 | 20.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.2 | 9.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.2 | 5.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.2 | 0.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.2 | 2.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.2 | 1.5 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.2 | 4.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.2 | 1.9 | REACTOME OPSINS | Genes involved in Opsins |
| 0.2 | 21.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.2 | 16.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.2 | 6.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.2 | 9.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.2 | 6.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.2 | 3.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 4.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.2 | 3.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.2 | 2.4 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.2 | 2.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.2 | 17.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.2 | 5.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.2 | 2.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 6.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 2.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.1 | 0.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.1 | 0.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.1 | 4.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 6.3 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 0.1 | 1.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.1 | 0.6 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.1 | 5.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.1 | 0.1 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
| 0.1 | 1.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
| 0.1 | 3.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 2.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 1.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.1 | 1.1 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
| 0.1 | 5.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 2.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.1 | 23.7 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
| 0.1 | 0.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.1 | 1.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.1 | 1.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.1 | 1.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.1 | 1.9 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.1 | 4.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 1.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.1 | 2.0 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.1 | 2.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 2.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 0.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.1 | 1.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.1 | 2.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.1 | 3.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.1 | 14.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.1 | 1.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.1 | 7.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.1 | 6.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.1 | 1.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.1 | 1.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.1 | 0.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.1 | 0.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.1 | 0.2 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
| 0.1 | 0.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.0 | 0.9 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
| 0.0 | 0.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.0 | 1.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.0 | 5.0 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.0 | 0.8 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
| 0.0 | 0.6 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.0 | 0.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.0 | 0.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.0 | 1.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.0 | 0.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.0 | 0.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
| 0.0 | 2.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.0 | 0.1 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
| 0.0 | 0.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.0 | 1.9 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
| 0.0 | 0.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.0 | 0.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.0 | 0.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.0 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |